Home » Medical Devices » Non-Invasive Prenatal Testing Market

Global Non-Invasive Prenatal Testing Market by Products (MaterniT21 PLUS, BambniTest, informaSeq Prenatal Test, Harmony Prenatal Test, Non-invasive Fetal Trisomy (NIFTY) Test, Verifi, PrenaTest, Panorama Test, VisibiliT Test) – Growth, Share, Opportunities & Competitive Analysis, 2016 – 2030

Price: $4999

Published: | Report ID: 14330 | Report Format : PDF

Key Highlights of the Report

How are the major segments performing in the Non-Invasive Prenatal Testing market?

  • In 2022, the high and average risk segment accounted for over 75% of total revenue. This is due to the increasing use of these diagnostics in high-risk cases and pregnancies involving women aged 35 and older.
  • The segment of cell-free DNA in maternal plasma tests generated the most revenue in 2022. Diverse genetic analyses are increasingly used to predict genetic disorders’ risk in prenatal care.
  • Due to the expanding prevalence of chromosomal abnormalities, trisomy dominated the market in 2022 with a share of over 50%. Many genetic diseases afflict India. Various studies indicate chromosomal abnormalities occur in 1 in 166 newborns in the United States. In contrast, trisomy 21 (down syndrome) has a high incidence rate of 1 in 800 births, culminating in 32,000 newborns with Down syndrome annually.
  • The consumables and reagents segment dominated the market with a share of more than 70% in 2022 due to major players offering a vast array of consumables and reagents for NIPT. More than 1.8 million pregnancies have been screened with the CE-marked Harmony IVD Kit from Roche, a NIPT test that has been extensively investigated and validated.
  • In 2022, Next-generation Sequencing (NGS) had the largest revenue share at over 29.61%. It has acquired a great deal of popularity at NIPT. It is frequently used to identify trisomy conditions, microdeletions, and chromosomal aneuploidies.
  • Due to the large number of diagnostic laboratories that offer NIPT worldwide, diagnostic laboratories held the largest revenue share in 2022, surpassing 60%. For the diagnosis of Trisomies 21, 18, and 13; Monosomy X; and other sex chromosomal abnormalities, labs such as MedGenome Labs Ltd. offer MedGenome Claria NIPT tests.

What is the Market Size of Non-Invasive Prenatal Testing regarding value?

The global Non-Invasive Prenatal Testing market is anticipated to grow at a substantial CAGR of 14.2% in the upcoming years. The global Non-Invasive Prenatal Testing industry was estimated to be worth USD 5.5 billion in 2022 and was expected to be worth USD 13.9 billion by 2030.

Design Element 2

Access crucial information at unmatched prices!

Request your free sample report today & start making informed decisions powered by Credence Research!

Download Free Sample

CTA Design Element 3

Which region dominated the Non-Invasive Prenatal Testing market?

In 2022, North America dominated the market with a share of over 40 percent, followed by Europe. High R&D expenditures, a high preterm birth rate, a well-established research framework, and developing whole-genome sequencing in North America will drive market growth. It is anticipated that the recent inclusion of non-invasive prenatal testing (NIPT) in the coverage plans of major insurance companies will increase the use of NIPT in the United States. Furthermore, 46% of average-risk pregnancies and 96% of high-risk pregnancies are eligible for reimbursement coverage in the United States. These factors are anticipated to impact the North American market’s growth positively.

Which are the key countries in the Non-Invasive Prenatal Testing market?

In addition, high diagnosis rates, increased adoption and public awareness, and the introduction of new and technologically advanced tests all contribute to expanding the market in the United States. In May 2021, for instance, Yourgene introduced IONA Care, a non-invasive prenatal test (NIPT) service that measures whether a pregnant woman is carrying a fetus with sexual chromosome aneuploidies (SCA) and autosomal aneuploidies (AA), in addition to the current IONA test, which provides screening for trisomies 21, 18, and 13 and fetal sex determination. Consequently, such product introductions will spur market expansion over the forecast period.

Germany is anticipated to lead the market for non-invasive prenatal testing (NIPT) during the forecast period. High preterm birth rate, high maternal mortality rate, and rising incidences of chromosomal abnormalities will likely increase adoption and demand for diagnostic tests in this region. Numerous research studies shed light on the effectiveness of prenatal care awareness campaigns. For example, in August 2022, the National Library of Medicine published a study stating that advances in antenatal care have led to a greater awareness of fetal malformations. Malpresentation is anticipated to enhance preparation for high-risk deliveries.

How is the economy impacting the global Non-Invasive Prenatal Testing growth?

Regarding economic impact, it is anticipated that the ongoing conflict between Russia and Ukraine will worsen during the forecast period. It is anticipated that the global economy will experience a development slowdown as a result of the massive and historic shocks caused by Russia’s aggression against Ukraine. The global market is anticipated to experience a decline in revenue due to factors such as rising inflationary pressures, declining consumer confidence and purchasing power, and escalating global risks. It is anticipated that supply chains will be disrupted to some degree, but that the market will be in shambles due to rising consumer interest.

What is the competitive environment of the Non-Invasive Prenatal Testing market?

This market is consolidated due to the wide variety of product offerings and robust distribution network of key players in developing and developed nations. In addition, businesses are implementing several strategic initiatives, such as partnerships, mergers, acquisitions, and product expansions, to strengthen their market position. Specifically, Next-Generation Genomic Co., Ltd. and Illumina, Inc. launched VeriSeq NIPT Solution v2 in Thailand in June 2021. End-to-end genome-wide noninvasive prenatal testing that is accurate, dependable, scalable, and quick. This market is consolidated due to the diverse product offerings and robust distribution networks of significant corporations in developed and developing nations. Current market leaders include Illumina, Sequenom Laboratories, LabCorp, Inc., and Natera. Certain factors, such as robust R&D efforts and a greater emphasis on introducing innovative products, are anticipated to aid in maintaining their market positions.

Non-Invasive Prenatal Testing Market

Executive Summary

What are the key trends in the Non-Invasive Prenatal Testing market?

  • In recent years, prenatal screening or testing has shifted its emphasis toward non-invasive tests, citing their clinical and economic benefits. The introduction of technologically advanced Non-Invasive tests by market participants, coupled with the demonstrated clinical efficacy of these tests, has been instrumental in bringing about this shift.
  • Numerous nations have adopted policies that make noninvasive prenatal tests the standard for prenatal screening instead of invasive tests. In the Netherlands, non-invasive procedures have been deemed the standard for screening pregnant women. Although invasive tests are useful for identifying specific disorders, global adoption of non-invasive tests has increased dramatically.

How is Down Syndrome Being Treated Using Non-Invasive Prenatal Testing?

This chromosomal disorder is trisomy 21, trisomy G, 47, XX,+21, and 47, XY,+21. It encompasses certain congenital disabilities, learning difficulties, and facial deformities. A child with Down syndrome may also have cardiac defects, vision, and hearing difficulties. According to April 2021 data from the Centers for Disease Control and Prevention, Down syndrome is the most frequently diagnosed chromosomal disorder in the United States. Approximately 6,000 infants are born annually in the United States with Down syndrome. This means that Down syndrome affects approximately 1 in 700 newborns. Consequently, the rising incidence rate of Down syndrome is anticipated to generate lucrative growth opportunities for the market during the forecast period. Non-invasive prenatal testing (NIPT) detects Down syndrome by analyzing cell-free DNA (cfDNA) circulating in the mother’s blood. With the successful incorporation of noninvasive prenatal testing (NIPT) for detecting Down syndrome into routine prenatal care, patients must be aware of the associated risks, benefits, and limitations to make informed decisions. Non-invasive prenatal testing (NIPT) has several advantages over actual prenatal tests, such as maternal serum screening (MSS). According to the study by Stanislav Birko et al. published in January 2022, non-invasive prenatal testing (NIPT) for the screening of Down syndrome can be performed as early as the ninth week of pregnancy, poses no risk of miscarriage, and has a high sensitivity (99.9%) and specificity (98%) for detecting the presence of Down syndrome (trisomy 21). As a result, the demand for these technologies has increased, and many developing nations are adopting them, which is anticipated to drive the segment’s growth.

Which are the key investments by the Non-Invasive Prenatal Testing market players?

This market is consolidated due to major corporations’ diverse product offerings and robust distribution networks in developed and developing countries. Illumina, Inc., Sequenom Laboratories, LabCorp, Inc., and Natera are the market leaders. Certain factors, such as robust research and development efforts and a greater emphasis on introducing innovative products, are anticipated to aid in maintaining their market positions. As part of the Q-Sub process, Natera Inc. submitted a pre-submission to the Food and Drug Administration (FDA) for its panorama non-invasive prenatal test (NIPT) in August 2022. In June 2022, the company submitted a pre-submission for fetal chromosomal aneuploidies and 22q11.2 deletion syndrome.  Pacific Biosciences inked a definitive merger agreement to acquire San Diego-based Omniome in July 2021. This partnership will assist in expanding market opportunities for sequencing in novel ways that will benefit consumers. Through its novel approach, Omniome will facilitate the development of a precise short-read sequencing platform for large, rapidly expanding clinical application areas such as oncology and noninvasive prenatal testing.

Some major players in the Non-Invasive Prenatal Testing market are Genesis Genetics (CooperSurgical; Inc.); Centogene N.V.; Natera, Inc.; Illumina, Inc. (Verinata Health, Inc.); Eurofins LifeCodexx GmbH; MedGenome Labs Ltd.; Myriad Women’s Health, Inc. (Counsyl; Inc.); F. Hoffmann-La Roche Ltd. (Ariosa Diagnostics); Progenity, Inc.; QIAGEN; Laboratory Corp. of America Holdings; Quest Diagnostics, Inc.

What are the Major Driving Factors for the Non-Invasive Prenatal Testing Market?

High demand for early Non-Invasive Prenatal Testing (NIPT) and enhancements in the reimbursement scenario are expected to drive market growth during the forecast period. The reimbursement for noninvasive prenatal diagnostics varies across insurance plans due to contract differences. The prices listed for NIPT range from over $2,000 to less than $1,000. However, research indicates that first-line NIPT screenings have become extremely cost-effective and are now available at prices ranging from $619 to $744. Diverse nations, including the Netherlands, are implementing policies to entirely reimburse NIPT in the second trimester, increasing the use of these tests. In addition, countries like Germany intend to reimburse noninvasive prenatal diagnostics for chromosomal disorders like Down syndrome. In various countries, the demand for NIPT is increasing due to several factors, including physicians opting for advanced genetic testing for high-risk pregnancies, a desire to defer pregnancy, and an increase in pregnancy-related complications in the third or second trimester. Using invasive prenatal testing techniques, such as chorionic villus sampling and amniocentesis, can result in complications such as miscarriage. This has resulted in a decline in these procedures and an increased demand for more effective, noninvasive, and secure tests. Using cell-free fetal DNA (cffDNA) that circulates in the mother’s blood, NIPT can detect common trisomies in the fetus, such as Turner syndrome, Down syndrome, fetal rhesus D status, and sex chromosome disorders, as well as determine fetal sex.

What are the Major Risks for the Non-Invasive Prenatal Testing Market?

In many developing nations, the high cost of these procedures, which makes them relatively unaffordable, will likely limit their adoption. According to a Future Medicine article, the average cost of NIPT in India is between USD 350 and USD 400. This has restricted their adoption in developing nations. In addition, the lack of awareness regarding the risks of genetic abnormalities among the general population in developing nations would hinder development. In addition, the lower per capita healthcare expenditures and lack of adequate reimbursement policies for tests are additional factors that may hinder the growth of the global market for noninvasive prenatal testing.

Which is the key application in the Non-Invasive Prenatal Testing market?

In 2022, the segment of cell-free DNA in maternal plasma assays accounted for over 42.8% of total revenue. Diverse genetic analyses are increasingly used to predict genetic disorders’ risk in prenatal care. In addition to microdeletions and sex chromosomal abnormalities, whole-genome sequencing now enables the detection of numerous additional chromosomal abnormalities, such as microdeletions. Ultrasound detection is utilized as a supplement to the Cell-free DNA-based NIPT test, decreasing this segment’s market share. However, recent technological advances and 3D-4D imaging have enhanced the test’s real-time monitoring, safety, and efficacy, which is anticipated to further propel the segment’s growth. In May 2022, for instance, General Electric Company (GE Healthcare) invested approximately USD 50 million in the Israeli startup Pulsenmore. This enables expectant parents to chart their pregnancies and conduct self-scans at home.

How is the Non-Invasive Prenatal Testing market performing in regions?

The market in Asia-Pacific is anticipated to grow relatively faster than other regions. There is a growing demand for prenatal testing for chromosomal disorders in developing nations such as China and India. This, along with domestic market participants emphasizing strategies such as partnerships and collaborations with global market participants, is anticipated to result in the introduction of new products and tests. In June 2021, for instance, Illumina and Next-generation Genomic Thailand will launch a next-generation sequencing (NGS)-based VeriSeq NIPT Solution v2 in the country. This will enable NGG Thailand to offer the Qualifi Prenatal Test and become the first lab in Southeast Asia to detect anomalies missed by targeted assays.

What is the regulatory landscape for the Non-Invasive Prenatal Testing market?

Numerous NIPT tests analyze cell-free DNA from a maternal blood sample to screen for embryonic aneuploidy, including common chromosomal conditions such as trisomy 21 (Down syndrome), trisomy 18 (Edwards syndrome), and trisomy 13 (Patau syndrome). NIPT is the most sensitive and specific screening test for chromosomal alterations and could, among other things, eliminate the need for more invasive procedures.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

What are the major players planning for the future of the Non-Invasive Prenatal Testing market?

Market leaders emphasize new product development to strengthen their portfolio and provide customers with innovative products. In March 2020, Agilent Technologies released three new microarrays to assist cytogenetic laboratories with prenatal and postnatal research. In constitutional DNA samples, the probes on microarrays enable high-resolution detection of copy number variation and copy-neutral loss of heterozygosity associated with neuropsychiatric disorders, developmental delay, intellectual disability, and congenital anomalies.

REPORT ATTRIBUTE DETAILS
Non-Invasive Prenatal Testing Market by Volume No
Non-Invasive Prenatal Testing Market by Value Yes
Non-Invasive Prenatal Testing Market, Tornado Analysis Yes
Non-Invasive Prenatal Testing Market, STAR Analysis Yes
Non-Invasive Prenatal Testing Market, SRC Analysis Yes
Non-Invasive Prenatal Testing Market, Import-Export Data Yes (On Demand)
Non-Invasive Prenatal Testing Market Pricing Analysis Yes (On Demand)
Non-Invasive Prenatal Testing Market Segment Analysis By Gestation Period Outlook (0-12 Weeks, 13-24 Weeks, and 25-36 Weeks

By Pregnancy Risk (High & Average Risk and Low Risk)

By Method (Ultrasound Detection, Biochemical Screening Tests, and Cell-free DNA in Maternal Plasma Tests)

By Technology (NGS, Array Technology, PCR, and Others)

By Product (Consumables & Reagents and Instruments)

Application (Trisomy, Microdeletion Syndrome, and Other Applications

End-use (Hospitals & Clinics and Diagnostic Laboratories)

Non-Invasive Prenatal Testing Market, Regional Analysis North America (US and Canada)

Europe (Germany, UK, France, Italy, Spain, and Rest of Europe)

Asia Pacific (China, India, Japan, South Korea, South East Asia, and Rest of Asia Pacific)

Latin America (Brazil, Mexico, and Rest of Latin America)

Middle East and Africa (GCC Countries, South Africa, and Rest of Middle East and Africa)

Non-Invasive Prenatal Testing Market Key Companies Genesis Genetics (CooperSurgical; Inc.); Natera, Inc.; Centogene N.V.; Illumina, Inc. (Verinata Health, Inc.); Eurofins LifeCodexx GmbH; MedGenome Labs Ltd.; F. Hoffmann-La Roche Ltd. (Ariosa Diagnostics); Myriad Women’s Health, Inc. (Counsyl; Inc.); QIAGEN; Laboratory Corp. of America Holdings; Progenity, Inc.; Quest Diagnostics, Inc.
Non-Invasive Prenatal Testing Market Competitive Landscape Market Share Analysis

Competitive Benchmarking

Key Players Market Positioning

Geographical Presence Analysis

Major Strategies Adopted

Segmentation of Global Non-Invasive Prenatal Testing Market-

Global Non-Invasive Prenatal Testing Market – By Gestation Period

  • 0-12 Weeks
  • 13-24 Weeks
  • 25-36 Weeks

Global Non-Invasive Prenatal Testing Market – By Pregnancy Risks

  • High & Average Risk
  • Low Risk

 Global Non-Invasive Prenatal Testing Market – By Method

  • Ultrasound Detection
  • Biochemical Screening Tests
  • Cell-free DNA in Maternal Plasma Tests

Global Non-Invasive Prenatal Testing Market – By Technology

  • NGS
  • Array Technology
  • PCR
  • Others

Global Non-Invasive Prenatal Testing Market – By Product

  • Consumables & Reagents
  • Instruments

Global Non-Invasive Prenatal Testing Market – By Application

  • Trisomy
  • Microdeletion Syndrome
  • Other Applications

Global Non-Invasive Prenatal Testing Market – By End Use

  • Hospitals & Clinics
  • Diagnostic Laboratories

Global Non-Invasive Prenatal Testing Market – By Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • South-east Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East and Africa

1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offeri0-12 Weeks
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I – Secondary Research
1.3.2. Phase II – Data Modelling
1.3.2.1. Company Share Analysis Model
1.3.2.2. Revenue Based Modelling
1.3.3. Phase III – Primary Research
1.3.4. Research Limitations
1.3.5. Assumptions
1.4. Market Introduction
1.5. Market Research Scope

2. Executive Summary
2.1. Market Snapshot: Global Non-Invasive Prenatal Testing Market
2.2. Global Non-Invasive Prenatal Testing Market, By Gestation Period
2.3. Global Non-Invasive Prenatal Testing Market, By Pregnancy Risk
2.4. Global Non-Invasive Prenatal Testing Market, By Method
2.5. Global Non-Invasive Prenatal Testing Market, By Technology
2.6. Global Non-Invasive Prenatal Testing Market, By Application
2.7. Global Non-Invasive Prenatal Testing Market, By Products
2.8. Global Non-Invasive Prenatal Testing Market, By End User
2.9. Global Non-Invasive Prenatal Testing Market, By Region

3. Market Dynamics & Factors Analysis
3.1. Introduction
3.1.1. Global Non-Invasive Prenatal Testing Market Value, 2017-2030, (US$ Mn)
3.1.2. Y-o-Y Growth Trend Analysis
3.2. Market Dynamics
3.2.1. Market Drivers
3.2.1.1. Driver 1
3.2.1.2. Driver 2
3.2.1.3. Driver 3
3.2.2. Market Restraints
3.2.2.1. Restraint 1
3.2.2.2. Restraint 2
3.2.3. Market Opportunities
3.2.3.1. Opportunity 1
3.2.3.2. Opportunity 2
3.2.4. Major Industry Challenges
3.2.4.1. Challenge 1
3.2.4.2. Challenge 2
3.3. Growth and Development and Extracellular Vesicles Patterns
3.4. Investment Feasibility Analysis
3.5. Market Opportunity Analysis
3.5.1. Gestation Period
3.5.2. Pregnancy Risk
3.5.3. Method
3.5.4. Technology
3.5.5. End User
3.5.6. Products
3.5.7. End User
3.5.8. Geography

4. Premium Insights
4.1. STAR (Situation, Task, Action, Results) Analysis
4.2. Porter’s Five Forces Analysis
4.2.1. Threat of New Entrants
4.2.2. Bargaining Power of Buyers/Consumers
4.2.3. Bargaining Power of Suppliers
4.2.4. Threat of Substitute Types
4.2.5. Intensity of Competitive Rivalry
4.3. Key Market Trends
4.3.1. Demand Side Trends
4.3.2. Supply Side Trends
4.4. Value Chain Analysis
4.5. Gestation Period Analysis
4.6. Analysis and Recommendations
4.7. Marketing Strategy Analysis
4.7.1. Direct Marketing
4.7.2. Indirect Marketing
4.7.3. Marketing Channel Development Trend

5. Market Positioning of Key Players, 2022
5.1. Company market share of key players, 2022
5.2. Competitive Benchmarking
5.3. Market Positioning of Key Vendors
5.4. Geographical Presence Analysis
5.5. Major Strategies Adopted by Key Players
5.5.1. Key Strategies Analysis
5.5.2. Mergers and Acquisitions
5.5.3. Partnerships
5.5.4. Product Launch
5.5.5. Geographical Expansion
5.5.6. Others

6. Economic Impact Analysis
6.1. Recession Impact
6.1.1. North America
6.1.2. Europe
6.1.3. Asia Pacific
6.1.4. Latin America
6.1.5. Middle East and Africa
6.2. Ukraine-Russia War Impact
6.2.1. North America
6.2.2. Europe
6.2.3. Asia Pacific
6.2.4. Latin America
6.2.5. Middle East and Africa
6.3. COVID-19 Impact Analysis
6.3.1. North America
6.3.2. Europe
6.3.3. Asia Pacific
6.3.4. Latin America
6.3.5. Middle East and Africa

7. Global Non-Invasive Prenatal Testing Market, By Gestation Period
7.1. Global Non-Invasive Prenatal Testing Market Overview, by Gestation Period
7.1.1. Global Non-Invasive Prenatal Testing Market Revenue Share, By Gestation Period, 2022 Vs 2030 (in %)
7.2. 0-12 Weeks
7.2.1. Global Non-Invasive Prenatal Testing Market, By Region, 2017-2030 (US$ Mn)
7.3. 13-24 Weeks
7.3.1. Global Non-Invasive Prenatal Testing Market, By Region, 2017-2030 (US$ Mn)
7.4. 25-36 Weeks
7.4.1. Global Non-Invasive Prenatal Testing Market, By Region, 2017-2030 (US$ Mn)

8. Global Non-Invasive Prenatal Testing Market, By Pregnancy Risk
8.1. Global Non-Invasive Prenatal Testing Market Overview, by Pregnancy Risk
8.1.1. Global Non-Invasive Prenatal Testing Market, By Pregnancy Risk, 2022 vs 2030 (in %)
8.2. High & Average Risk
8.2.1. Global Non-Invasive Prenatal Testing Market, By Region, 2017-2030 (US$ Mn)
8.3. Low Risk
8.3.1. Global Non-Invasive Prenatal Testing Market, By Region, 2017-2030 (US$ Mn)

9. Global Non-Invasive Prenatal Testing Market, by Method, 2017-2030 (US$ Mn)
9.1. Global Non-Invasive Prenatal Testing Market Overview, by Method
9.1.1. Global Non-Invasive Prenatal Testing Market, By Method, 2022 vs 2030 (in%)
9.2. Ultrasound Detection
9.2.1. Global Non-Invasive Prenatal Testing Market, By Region, 2017-2030 (US$ Mn)
9.3. Biochemical Screening Tests
9.3.1. Global Non-Invasive Prenatal Testing Market, By Region, 2017-2030 (US$ Mn)
9.4. Cell-free DNA in Maternal Plasma Tests
9.4.1. Global Non-Invasive Prenatal Testing Market, By Region, 2017-2030 (US$ Mn)

10. Global Non-Invasive Prenatal Testing Market, by Technology, 2017-2030 (US$ Mn)
10.1. Global Non-Invasive Prenatal Testing Market Overview, by Technology
10.1.1. Global Non-Invasive Prenatal Testing Market, By Method, 2022 vs 2030 (in%)
10.2. NGS
10.2.1. Global Non-Invasive Prenatal Testing Market, By Region, 2017-2030 (US$ Mn)
10.3. Array Technology
10.3.1. Global Non-Invasive Prenatal Testing Market, By Region, 2017-2030 (US$ Mn)
10.4. PCR
10.4.1. Global Non-Invasive Prenatal Testing Market, By Region, 2017-2030 (US$ Mn)
10.5. Others
10.5.1. Global Non-Invasive Prenatal Testing Market, By Region, 2017-2030 (US$ Mn)

11. Global Non-Invasive Prenatal Testing Market, by Application, 2017-2030 (US$ Mn)
11.1. Global Non-Invasive Prenatal Testing Market Overview, by Application
11.1.1. Global Non-Invasive Prenatal Testing Market, By Application, 2022 vs 2030 (in%)
11.2. Trisomy
11.2.1. Global Non-Invasive Prenatal Testing Market, By Region, 2017-2030 (US$ Mn)
11.3. Microdeletion Syndrome
11.3.1. Global Non-Invasive Prenatal Testing Market, By Region, 2017-2030 (US$ Mn)
11.4. Other Applications
11.4.1. Global Non-Invasive Prenatal Testing Market, By Region, 2017-2030 (US$ Mn)

12. Global Non-Invasive Prenatal Testing Market, by Products, 2017-2030 (US$ Mn)
12.1. Global Non-Invasive Prenatal Testing Market Overview, by Products
12.1.1. Global Non-Invasive Prenatal Testing Market, By Products, 2022 vs 2030 (in%)
12.2. Consumables & Reagents
12.2.1. Global Non-Invasive Prenatal Testing Market, By Region, 2017-2030 (US$ Mn)
12.3. Instruments
12.3.1. Global Non-Invasive Prenatal Testing Market, By Region, 2017-2030 (US$ Mn)

13. Global Non-Invasive Prenatal Testing Market, by End User, 2017-2030 (US$ Mn)
13.1. Global Non-Invasive Prenatal Testing Market Overview, by End User
13.1.1. Global Non-Invasive Prenatal Testing Market, By End User, 2022 vs 2030 (in%)
13.2. Hospitals & Clinics
13.2.1. Global Non-Invasive Prenatal Testing Market, By Region, 2017-2030 (US$ Mn)
13.3. Diagnostic Laboratories
13.3.1. Global Non-Invasive Prenatal Testing Market, By Region, 2017-2030 (US$ Mn)

14. Global Non-Invasive Prenatal Testing Market, By Region
14.1. Global Non-Invasive Prenatal Testing Market Overview, by Region
14.1.1. Global Non-Invasive Prenatal Testing Market, By Region, 2022 vs 2030 (in%)
14.2. Gestation Period
14.2.1. Global Non-Invasive Prenatal Testing Market, By Gestation Period, 2017-2030 (US$ Mn)
14.3. Pregnancy Risk
14.3.1. Global Non-Invasive Prenatal Testing Market, By Pregnancy Risk, 2017-2030 (US$ Mn)
14.4. Method
14.4.1. Global Non-Invasive Prenatal Testing Market, By Method, 2017-2030 (US$ Mn)
14.5. Technology
14.5.1. Global Non-Invasive Prenatal Testing Market, By Technology, 2017-2030 (US$ Mn)
14.6. Application
14.6.1. Global Non-Invasive Prenatal Testing Market, By Application, 2017-2030 (US$ Mn)
14.7. Products
14.7.1. Global Non-Invasive Prenatal Testing Market, By Products, 2017-2030 (US$ Mn)
14.8. End User
14.8.1. Global Non-Invasive Prenatal Testing Market, By End User, 2017-2030 (US$ Mn)

15. North America Non-Invasive Prenatal Testing Market Analysis
15.1. North America Non-Invasive Prenatal Testing Market, by Gestation Period, 2017-2030(US$ Mn)
15.1.1. Overview
15.1.2. SRC Analysis
15.2. North America Non-Invasive Prenatal Testing Market, by Pregnancy Risk, 2017-2030(US$ Mn)
15.2.1. Overview
15.2.2. SRC Analysis
15.3. North America Non-Invasive Prenatal Testing Market, by Method, 2017-2030(US$ Mn)
15.3.1. Overview
15.3.2. SRC Analysis
15.4. North America Non-Invasive Prenatal Testing Market, by Technology, 2017-2030(US$ Mn)
15.4.1. Overview
15.4.2. SRC Analysis
15.5. North America Non-Invasive Prenatal Testing Market, by Application, 2017-2030(US$ Mn)
15.5.1. Overview
15.5.2. SRC Analysis
15.6. North America Non-Invasive Prenatal Testing Market, by Products, 2017-2030(US$ Mn)
15.6.1. Overview
15.6.2. SRC Analysis
15.7. North America Non-Invasive Prenatal Testing Market, by End User, 2017-2030(US$ Mn)
15.7.1. Overview
15.7.2. SRC Analysis
15.8. North America Non-Invasive Prenatal Testing Market, by Country, 2017-2030 (US$ Mn)
15.8.1. North America Non-Invasive Prenatal Testing Market, by Country, 2022 Vs 2030 (in%)
15.8.2. U.S.
15.8.2.1. U.S. Non-Invasive Prenatal Testing Market Estimates and Forecast, 2017-2030 (US$ Mn)
15.8.2.2. U.S. Non-Invasive Prenatal Testing, By Gestation Period, 2017-2030 (US$ Mn)
15.8.2.3. U.S. Non-Invasive Prenatal Testing, By Pregnancy Risk, 2017-2030 (US$ Mn)
15.8.2.4. U.S. Non-Invasive Prenatal Testing, By Method, 2017-2030 (US$ Mn)
15.8.2.5. U.S. Non-Invasive Prenatal Testing, By Technology, 2017-2030 (US$ Mn)
15.8.2.6. U.S. Non-Invasive Prenatal Testing, By Application, 2017-2030 (US$ Mn)
15.8.2.7. U.S. Non-Invasive Prenatal Testing, By Products, 2017-2030 (US$ Mn)
15.8.2.8. U.S. Non-Invasive Prenatal Testing, By End User, 2017-2030 (US$ Mn)
15.8.3. Canada
15.8.3.1. Canada Non-Invasive Prenatal Testing Market Estimates and Forecast, 2017-2030 (US$ Mn)
15.8.3.2. Canada Non-Invasive Prenatal Testing, By Gestation Period, 2017-2030 (US$ Mn)
15.8.3.3. Canada Non-Invasive Prenatal Testing, By Pregnancy Risk, 2017-2030 (US$ Mn)
15.8.3.4. Canada Non-Invasive Prenatal Testing, By Method, 2017-2030 (US$ Mn)
15.8.3.5. Canada Non-Invasive Prenatal Testing, By Technology, 2017-2030 (US$ Mn)
15.8.3.6. Canada Non-Invasive Prenatal Testing, By Application, 2017-2030 (US$ Mn)
15.8.3.7. Canada Non-Invasive Prenatal Testing, By Products, 2017-2030 (US$ Mn)
15.8.3.8.
15.8.3.9. Canada Non-Invasive Prenatal Testing, By End User, 2017-2030 (US$ Mn)
15.8.3.10.
15.8.4. Mexico
15.8.4.1. Mexico Non-Invasive Prenatal Testing Market Estimates and Forecast, 2017-2030 (US$ Mn)
15.8.4.2. Mexico Non-Invasive Prenatal Testing, By Gestation Period, 2017-2030 (US$ Mn)
15.8.4.3. Mexico Non-Invasive Prenatal Testing, By Pregnancy Risk, 2017-2030 (US$ Mn)
15.8.4.4. Mexico Non-Invasive Prenatal Testing, By Method, 2017-2030 (US$ Mn)
15.8.4.5. Mexico Non-Invasive Prenatal Testing, By Technology, 2017-2030 (US$ Mn)
15.8.4.6. Mexico Non-Invasive Prenatal Testing, By Application, 2017-2030 (US$ Mn)
15.8.4.7. Mexico Non-Invasive Prenatal Testing, By Products, 2017-2030 (US$ Mn)
15.8.4.8. Mexico Non-Invasive Prenatal Testing, By End User, 2017-2030 (US$ Mn)

16. Europe Non-Invasive Prenatal Testing Market Analysis
16.1. Europe Non-Invasive Prenatal Testing Market, by Gestation Period, 2017-2030(US$ Mn)
16.1.1. Overview
16.1.2. SRC Analysis
16.2. Europe Non-Invasive Prenatal Testing Market, by Pregnancy Risk, 2017-2030(US$ Mn)
16.2.1. Overview
16.2.2. SRC Analysis
16.3. Europe Non-Invasive Prenatal Testing Market, by Method, 2017-2030(US$ Mn)
16.3.1. Overview
16.3.2. SRC Analysis
16.4. Europe Non-Invasive Prenatal Testing Market, by Technology, 2017-2030(US$ Mn)
16.4.1. Overview
16.4.2. SRC Analysis
16.5. Europe Non-Invasive Prenatal Testing Market, by Application, 2017-2030(US$ Mn)
16.5.1. Overview
16.5.2. SRC Analysis
16.6. Europe Non-Invasive Prenatal Testing Market, by Products, 2017-2030(US$ Mn)
16.6.1. Overview
16.6.2. SRC Analysis
16.7. Europe Non-Invasive Prenatal Testing Market, by End User, 2017-2030(US$ Mn)
16.7.1. Overview
16.7.2. SRC Analysis
16.8. Europe Non-Invasive Prenatal Testing Market, by Country, 2017-2030 (US$ Mn)
16.8.1. Europe Non-Invasive Prenatal Testing Market, by Country, 2022 Vs 2030 (in%)
16.8.2. Germany
16.8.2.1. Germany Non-Invasive Prenatal Testing Market Estimates and Forecast, 2017-2030 (US$ Mn)
16.8.2.2. Germany Non-Invasive Prenatal Testing, By Gestation Period, 2017-2030 (US$ Mn)
16.8.2.3. Germany Non-Invasive Prenatal Testing, By Pregnancy Risk, 2017-2030 (US$ Mn)
16.8.2.4. Germany Non-Invasive Prenatal Testing, By Method, 2017-2030 (US$ Mn)
16.8.2.5. Germany Non-Invasive Prenatal Testing, By Technology, 2017-2030 (US$ Mn)
16.8.2.6. Germany Non-Invasive Prenatal Testing, By Application, 2017-2030 (US$ Mn)
16.8.2.7. Germany Non-Invasive Prenatal Testing, By Products, 2017-2030 (US$ Mn)
16.8.2.8. Germany Non-Invasive Prenatal Testing, By End User, 2017-2030 (US$ Mn)
16.8.3. France
16.8.3.1. France Non-Invasive Prenatal Testing Market Estimates and Forecast, 2017-2030 (US$ Mn)
16.8.3.2. France Non-Invasive Prenatal Testing, By Gestation Period, 2017-2030 (US$ Mn)
16.8.3.3. France Non-Invasive Prenatal Testing, By Pregnancy Risk, 2017-2030 (US$ Mn)
16.8.3.4. France Non-Invasive Prenatal Testing, By Method, 2017-2030 (US$ Mn)
16.8.3.5. France Non-Invasive Prenatal Testing, By Technology, 2017-2030 (US$ Mn)
16.8.3.6. France Non-Invasive Prenatal Testing, By Application, 2017-2030 (US$ Mn)
16.8.3.7. France Non-Invasive Prenatal Testing, By Products, 2017-2030 (US$ Mn)
16.8.3.8. France Non-Invasive Prenatal Testing, By End User, 2017-2030 (US$ Mn)
16.8.4. UK
16.8.4.1. UK Non-Invasive Prenatal Testing Market Estimates and Forecast, 2017-2030 (US$ Mn)
16.8.4.2. UK Non-Invasive Prenatal Testing, By Gestation Period, 2017-2030 (US$ Mn)
16.8.4.3. UK Non-Invasive Prenatal Testing, By Pregnancy Risk, 2017-2030 (US$ Mn)
16.8.4.4. UK Non-Invasive Prenatal Testing, By Method, 2017-2030 (US$ Mn)
16.8.4.5. UK Non-Invasive Prenatal Testing, By Technology, 2017-2030 (US$ Mn)
16.8.4.6. UK Non-Invasive Prenatal Testing, By Application, 2017-2030 (US$ Mn)
16.8.4.7. UK Non-Invasive Prenatal Testing, By Products, 2017-2030 (US$ Mn)
16.8.4.8. UK Non-Invasive Prenatal Testing, By End User, 2017-2030 (US$ Mn)
16.8.5. Italy
16.8.5.1. Italy Non-Invasive Prenatal Testing Market Estimates and Forecast, 2017-2030 (US$ Mn)
16.8.5.2. Italy Non-Invasive Prenatal Testing, By Gestation Period, 2017-2030 (US$ Mn)
16.8.5.3. Italy Non-Invasive Prenatal Testing, By Pregnancy Risk, 2017-2030 (US$ Mn)
16.8.5.4. Italy Non-Invasive Prenatal Testing, By Method, 2017-2030 (US$ Mn)
16.8.5.5. Italy Non-Invasive Prenatal Testing, By Technology, 2017-2030 (US$ Mn)
16.8.5.6. Italy Non-Invasive Prenatal Testing, By Application, 2017-2030 (US$ Mn)
16.8.5.7. Italy Non-Invasive Prenatal Testing, By Products, 2017-2030 (US$ Mn)
16.8.5.8. Italy Non-Invasive Prenatal Testing, By End User, 2017-2030 (US$ Mn)
16.8.6. Spain
16.8.6.1. Spain Non-Invasive Prenatal Testing Market Estimates and Forecast, 2017-2030 (US$ Mn)
16.8.6.2. Spain Non-Invasive Prenatal Testing, By Gestation Period, 2017-2030 (US$ Mn)
16.8.6.3. Spain Non-Invasive Prenatal Testing, By Pregnancy Risk, 2017-2030 (US$ Mn)
16.8.6.4. Spain Non-Invasive Prenatal Testing, By Method, 2017-2030 (US$ Mn)
16.8.6.5. Spain Non-Invasive Prenatal Testing, By Technology, 2017-2030 (US$ Mn)
16.8.6.6. Spain Non-Invasive Prenatal Testing, By Application, 2017-2030 (US$ Mn)
16.8.6.7. Spain Non-Invasive Prenatal Testing, By Products, 2017-2030 (US$ Mn)
16.8.6.8. Spain Non-Invasive Prenatal Testing, By End User, 2017-2030 (US$ Mn)
16.8.7. Rest of Europe
16.8.7.1. Rest of Europe Non-Invasive Prenatal Testing Market Estimates and Forecast, 2017-2030 (US$ Mn)
16.8.7.2. Rest of Europe Non-Invasive Prenatal Testing, By Gestation Period, 2017-2030 (US$ Mn)
16.8.7.3. Rest of Europe Non-Invasive Prenatal Testing, By Pregnancy Risk, 2017-2030 (US$ Mn)
16.8.7.4. Rest of Europe Non-Invasive Prenatal Testing, By Method, 2017-2030 (US$ Mn)
16.8.7.5. Rest of Europe Non-Invasive Prenatal Testing, By Technology, 2017-2030 (US$ Mn)
16.8.7.6. Rest of Europe Non-Invasive Prenatal Testing, By Application, 2017-2030 (US$ Mn)
16.8.7.7. Rest of Europe Non-Invasive Prenatal Testing, By Products, 2017-2030 (US$ Mn)
16.8.7.8. Rest of Europe Non-Invasive Prenatal Testing, By End User, 2017-2030 (US$ Mn)

17. Asia Pacific Non-Invasive Prenatal Testing Market Analysis
17.1. Asia Pacific Non-Invasive Prenatal Testing Market, by Gestation Period, 2017-2030(US$ Mn)
17.1.1. Overview
17.1.2. SRC Analysis
17.2. Asia Pacific Non-Invasive Prenatal Testing Market, by Pregnancy Risk, 2017-2030(US$ Mn)
17.2.1. Overview
17.2.2. SRC Analysis
17.3. Asia Pacific Non-Invasive Prenatal Testing Market, by Method, 2017-2030(US$ Mn)
17.3.1. Overview
17.3.2. SRC Analysis
17.4. Asia Pacific Non-Invasive Prenatal Testing Market, by Technology, 2017-2030(US$ Mn)
17.4.1. Overview
17.4.2. SRC Analysis
17.5. Asia Pacific Non-Invasive Prenatal Testing Market, by Application, 2017-2030(US$ Mn)
17.5.1. Overview
17.5.2. SRC Analysis
17.6. Asia Pacific Non-Invasive Prenatal Testing Market, by Products, 2017-2030(US$ Mn)
17.6.1. Overview
17.6.2. SRC Analysis
17.7. Asia Pacific Non-Invasive Prenatal Testing Market, by End User, 2017-2030(US$ Mn)
17.7.1. Overview
17.7.2. SRC Analysis
17.8. Asia Pacific Non-Invasive Prenatal Testing Market, by Country, 2017-2030 (US$ Mn)
17.8.1. Asia Pacific Non-Invasive Prenatal Testing Market, by Country, 2022 Vs 2030 (in%)
17.8.2. China
17.8.2.1. China Non-Invasive Prenatal Testing Market Estimates and Forecast, 2017-2030 (US$ Mn)
17.8.2.2. China Non-Invasive Prenatal Testing, By Gestation Period, 2017-2030 (US$ Mn)
17.8.2.3. China Non-Invasive Prenatal Testing, By Pregnancy Risk, 2017-2030 (US$ Mn)
17.8.2.4. China Non-Invasive Prenatal Testing, By Method, 2017-2030 (US$ Mn)
17.8.2.5. China Non-Invasive Prenatal Testing, By Technology, 2017-2030 (US$ Mn)
17.8.2.6. China Non-Invasive Prenatal Testing, By Application, 2017-2030 (US$ Mn)
17.8.2.7. China Non-Invasive Prenatal Testing, By Products, 2017-2030 (US$ Mn)
17.8.2.8. China Non-Invasive Prenatal Testing, By End User, 2017-2030 (US$ Mn)
17.8.3. Japan
17.8.3.1. Japan Non-Invasive Prenatal Testing Market Estimates and Forecast, 2017-2030 (US$ Mn)
17.8.3.2. Japan Non-Invasive Prenatal Testing, By Gestation Period, 2017-2030 (US$ Mn)
17.8.3.3. Japan Non-Invasive Prenatal Testing, By Pregnancy Risk, 2017-2030 (US$ Mn)
17.8.3.4. Japan Non-Invasive Prenatal Testing, By Method, 2017-2030 (US$ Mn)
17.8.3.5. Japan Non-Invasive Prenatal Testing, By Technology, 2017-2030 (US$ Mn)
17.8.3.6. Japan Non-Invasive Prenatal Testing, By Application, 2017-2030 (US$ Mn)
17.8.3.7. Japan Non-Invasive Prenatal Testing, By Products, 2017-2030 (US$ Mn)
17.8.3.8. Japan Non-Invasive Prenatal Testing, By End User, 2017-2030 (US$ Mn)
17.8.4. India
17.8.4.1. India Non-Invasive Prenatal Testing Market Estimates and Forecast, 2017-2030 (US$ Mn)
17.8.4.2. India Non-Invasive Prenatal Testing, By Gestation Period, 2017-2030 (US$ Mn)
17.8.4.3. India Non-Invasive Prenatal Testing, By Pregnancy Risk, 2017-2030 (US$ Mn)
17.8.4.4. India Non-Invasive Prenatal Testing, By Method, 2017-2030 (US$ Mn)
17.8.4.5. India Non-Invasive Prenatal Testing, By Technology, 2017-2030 (US$ Mn)
17.8.4.6. India Non-Invasive Prenatal Testing, By Application, 2017-2030 (US$ Mn)
17.8.4.7. India Non-Invasive Prenatal Testing, By Products, 2017-2030 (US$ Mn)
17.8.4.8. India Non-Invasive Prenatal Testing, By End User, 2017-2030 (US$ Mn)
17.8.5. South Korea
17.8.5.1. South Korea Non-Invasive Prenatal Testing Market Estimates and Forecast, 2017-2030 (US$ Mn)
17.8.5.2. South Korea Non-Invasive Prenatal Testing, By Gestation Period, 2017-2030 (US$ Mn)
17.8.5.3. South Korea Non-Invasive Prenatal Testing, By Pregnancy Risk, 2017-2030 (US$ Mn)
17.8.5.4. South Korea Non-Invasive Prenatal Testing, By Method, 2017-2030 (US$ Mn)
17.8.5.5. South Korea Non-Invasive Prenatal Testing, By Technology, 2017-2030 (US$ Mn)
17.8.5.6. South Korea Non-Invasive Prenatal Testing, By Application, 2017-2030 (US$ Mn)
17.8.5.7. South Korea Non-Invasive Prenatal Testing, By Products, 2017-2030 (US$ Mn)
17.8.5.8. South Korea Non-Invasive Prenatal Testing, By End User, 2017-2030 (US$ Mn)
17.8.6. South-East Asia
17.8.6.1. South-East Asia Non-Invasive Prenatal Testing Market Estimates and Forecast, 2017-2030 (US$ Mn)
17.8.6.2. South-East Asia Non-Invasive Prenatal Testing, By Gestation Period, 2017-2030 (US$ Mn)
17.8.6.3. South-East Asia Non-Invasive Prenatal Testing, By Pregnancy Risk, 2017-2030 (US$ Mn)
17.8.6.4. South Korea Non-Invasive Prenatal Testing, By Method, 2017-2030 (US$ Mn)
17.8.6.5. South Korea Non-Invasive Prenatal Testing, By Technology, 2017-2030 (US$ Mn)
17.8.6.6. South-East Asia Non-Invasive Prenatal Testing, By Application, 2017-2030 (US$ Mn)
17.8.6.7. South Korea Non-Invasive Prenatal Testing, By Products, 2017-2030 (US$ Mn)
17.8.6.8. South Korea Non-Invasive Prenatal Testing, By End User, 2017-2030 (US$ Mn)
17.8.7. Rest of Asia Pacific
17.8.7.1. Rest of Asia Pacific Non-Invasive Prenatal Testing Market Estimates and Forecast, 2017-2030 (US$ Mn)
17.8.7.2. Rest of Asia Pacific Non-Invasive Prenatal Testing, By Gestation Period, 2017-2030 (US$ Mn)
17.8.7.3. Rest of Asia Pacific Non-Invasive Prenatal Testing, By Pregnancy Risk, 2017-2030 (US$ Mn)
17.8.7.4. Rest of Asia Pacific Non-Invasive Prenatal Testing, By Method, 2017-2030 (US$ Mn)
17.8.7.5. Rest of Asia Pacific Non-Invasive Prenatal Testing, By Technology, 2017-2030 (US$ Mn)
17.8.7.6. Rest of Asia Pacific Non-Invasive Prenatal Testing, By Application, 2017-2030 (US$ Mn)
17.8.7.7. Rest of Asia Pacific Non-Invasive Prenatal Testing, By Products, 2017-2030 (US$ Mn)
17.8.7.8. Rest of Asia Pacific Non-Invasive Prenatal Testing, By End User, 2017-2030 (US$ Mn)

18. Latin America Non-Invasive Prenatal Testing Market Analysis
18.1. Latin America Non-Invasive Prenatal Testing Market, by Gestation Period, 2017-2030(US$ Mn)
18.1.1. Overview
18.1.2. SRC Analysis
18.2. Latin America Non-Invasive Prenatal Testing Market, by Pregnancy Risk, 2017-2030(US$ Mn)
18.2.1. Overview
18.2.2. SRC Analysis
18.3. Latin America Non-Invasive Prenatal Testing Market, by Method, 2017-2030(US$ Mn)
18.3.1. Overview
18.3.2. SRC Analysis
18.4. Latin America Non-Invasive Prenatal Testing Market, by Technology, 2017-2030(US$ Mn)
18.4.1. Overview
18.4.2. SRC Analysis
18.5. Latin America Non-Invasive Prenatal Testing Market, by Application, 2017-2030(US$ Mn)
18.5.1. Overview
18.5.2. SRC Analysis
18.6. Latin America Non-Invasive Prenatal Testing Market, by Products, 2017-2030(US$ Mn)
18.6.1. Overview
18.6.2. SRC Analysis
18.7. Latin America Non-Invasive Prenatal Testing Market, by End User, 2017-2030(US$ Mn)
18.7.1. Overview
18.7.2. SRC Analysis
18.8. Latin America Non-Invasive Prenatal Testing Market, by Country, 2017-2030 (US$ Mn)
18.8.1. Latin America Non-Invasive Prenatal Testing Market, by Country, 2022 Vs 2030 (in%)
18.8.2. Brazil
18.8.2.1. Brazil Non-Invasive Prenatal Testing Market Estimates and Forecast, 2017-2030 (US$ Mn)
18.8.2.2. Brazil Non-Invasive Prenatal Testing, By Gestation Period, 2017-2030 (US$ Mn)
18.8.2.3. Brazil Non-Invasive Prenatal Testing, By Pregnancy Risk, 2017-2030 (US$ Mn)
18.8.2.4. Brazil Non-Invasive Prenatal Testing, By Method, 2017-2030 (US$ Mn)
18.8.2.5. Brazil Non-Invasive Prenatal Testing, By Technology, 2017-2030 (US$ Mn)
18.8.2.6. Brazil Non-Invasive Prenatal Testing, By Application, 2017-2030 (US$ Mn)
18.8.2.7. Brazil Non-Invasive Prenatal Testing, By Products, 2017-2030 (US$ Mn)
18.8.2.8. Brazil Non-Invasive Prenatal Testing, By End User, 2017-2030 (US$ Mn)
18.8.3. Argentina
18.8.3.1. Argentina Non-Invasive Prenatal Testing Market Estimates and Forecast, 2017-2030 (US$ Mn)
18.8.3.2. Argentina Non-Invasive Prenatal Testing, By Gestation Period, 2017-2030 (US$ Mn)
18.8.3.3. Argentina Non-Invasive Prenatal Testing, By Pregnancy Risk, 2017-2030 (US$ Mn)
18.8.3.4. Argentina Non-Invasive Prenatal Testing, By Method, 2017-2030 (US$ Mn)
18.8.3.5. Argentina Non-Invasive Prenatal Testing, By Technology, 2017-2030 (US$ Mn)
18.8.3.6. Argentina Non-Invasive Prenatal Testing, By Application, 2017-2030 (US$ Mn)
18.8.3.7. Argentina Non-Invasive Prenatal Testing, By Products, 2017-2030 (US$ Mn)
18.8.3.8. Argentina Non-Invasive Prenatal Testing, By End User, 2017-2030 (US$ Mn)
18.8.4. Rest of Latin America
18.8.4.1. Rest of Latin America Non-Invasive Prenatal Testing Market Estimates and Forecast, 2017-2030 (US$ Mn)
18.8.4.2. Rest of Latin America Non-Invasive Prenatal Testing, By Gestation Period, 2017-2030 (US$ Mn)
18.8.4.3. Rest of Latin America Non-Invasive Prenatal Testing, By Pregnancy Risk, 2017-2030 (US$ Mn)
18.8.4.4. Rest of Latin America Non-Invasive Prenatal Testing, By Method, 2017-2030 (US$ Mn)
18.8.4.5. Rest of Latin America Non-Invasive Prenatal Testing, By Technology, 2017-2030 (US$ Mn)
18.8.4.6. Rest of Latin America Non-Invasive Prenatal Testing, By Application, 2017-2030 (US$ Mn)
18.8.4.7. Rest of Latin America Non-Invasive Prenatal Testing, By Products, 2017-2030 (US$ Mn)
18.8.4.8. Rest of Latin America Non-Invasive Prenatal Testing, By End User, 2017-2030 (US$ Mn)

19. Middle East and Africa Non-Invasive Prenatal Testing Market Analysis
19.1. Middle East and Africa Non-Invasive Prenatal Testing Market, by Gestation Period, 2017-2030(US$ Mn)
19.1.1. Overview
19.1.2. SRC Analysis
19.2. Middle East and Africa Non-Invasive Prenatal Testing Market, by Pregnancy Risk, 2017-2030(US$ Mn)
19.2.1. Overview
19.2.2. SRC Analysis
19.3. Middle East and Africa Non-Invasive Prenatal Testing Market, by Method, 2017-2030(US$ Mn)
19.3.1. Overview
19.3.2. SRC Analysis
19.4. Middle East and Africa Non-Invasive Prenatal Testing Market, by Technology, 2017-2030(US$ Mn)
19.4.1. Overview
19.4.2. SRC Analysis
19.5. Middle East and Africa Non-Invasive Prenatal Testing Market, by Application, 2017-2030(US$ Mn)
19.5.1. Overview
19.5.2. SRC Analysis
19.6. Middle East and Africa Non-Invasive Prenatal Testing Market, by Products, 2017-2030(US$ Mn)
19.6.1. Overview
19.6.2. SRC Analysis
19.7. Middle East and Africa Non-Invasive Prenatal Testing Market, by End User, 2017-2030(US$ Mn)
19.7.1. Overview
19.7.2. SRC Analysis
19.8. Middle East and Africa Non-Invasive Prenatal Testing Market, by Country, 2017-2030 (US$ Mn)
19.8.1. Middle East and Africa Non-Invasive Prenatal Testing Market, by Country, 2022 Vs 2030 (in%)
19.8.2. GCC Countries
19.8.2.1. GCC Countries Non-Invasive Prenatal Testing Market Estimates and Forecast, 2017-2030 (US$ Mn)
19.8.2.2. GCC Countries Non-Invasive Prenatal Testing, By Gestation Period, 2017-2030 (US$ Mn)
19.8.2.3. GCC Countries Non-Invasive Prenatal Testing, By Pregnancy Risk, 2017-2030 (US$ Mn)
19.8.2.4. GCC Countries Non-Invasive Prenatal Testing, By Method, 2017-2030 (US$ Mn)
19.8.2.5. GCC Non-Invasive Prenatal Testing, By Technology, 2017-2030 (US$ Mn)
19.8.2.6. GCC Countries Non-Invasive Prenatal Testing, By Application, 2017-2030 (US$ Mn)
19.8.2.7. GCC Countries Non-Invasive Prenatal Testing, By Products, 2017-2030 (US$ Mn)
19.8.2.8. GCC Non-Invasive Prenatal Testing, By End User, 2017-2030 (US$ Mn)
19.8.3. South Africa
19.8.3.1. South Africa Non-Invasive Prenatal Testing Market Estimates and Forecast, 2017-2030 (US$ Mn)
19.8.3.2. South Africa Non-Invasive Prenatal Testing, By Gestation Period, 2017-2030 (US$ Mn)
19.8.3.3. South Africa Non-Invasive Prenatal Testing, By Pregnancy Risk, 2017-2030 (US$ Mn)
19.8.3.4. South Africa Non-Invasive Prenatal Testing, By Method, 2017-2030 (US$ Mn)
19.8.3.5. South Africa Non-Invasive Prenatal Testing, By Technology, 2017-2030 (US$ Mn)
19.8.3.6. South Africa Non-Invasive Prenatal Testing, By Application, 2017-2030 (US$ Mn)
19.8.3.7. South Africa Non-Invasive Prenatal Testing, By Products, 2017-2030 (US$ Mn)
19.8.3.8. South Africa Non-Invasive Prenatal Testing, By End User, 2017-2030 (US$ Mn)
19.8.4. Rest of Middle East and Africa
19.8.4.1. Rest of Middle East and Africa Non-Invasive Prenatal Testing Market Estimates and Forecast, 2017-2030 (US$ Mn)
19.8.4.2. Rest of Middle East and Africa Non-Invasive Prenatal Testing, By Gestation Period, 2017-2030 (US$ Mn)
19.8.4.3. Rest of Middle East and Africa Non-Invasive Prenatal Testing, By Pregnancy Risk, 2017-2030 (US$ Mn)
19.8.4.4. Rest of Middle East and Africa Non-Invasive Prenatal Testing, By Method, 2017-2030 (US$ Mn)
19.8.4.5. Rest of Middle East and Africa Non-Invasive Prenatal Testing, By Technology, 2017-2030 (US$ Mn)
19.8.4.6. Rest of Middle East and Africa Non-Invasive Prenatal Testing, By Application, 2017-2030 (US$ Mn)
19.8.4.7. Rest of Middle East and Africa Non-Invasive Prenatal Testing, By Products, 2017-2030 (US$ Mn)
19.8.4.8. Rest of Middle East and Africa Non-Invasive Prenatal Testing, By End User, 2017-2030 (US$ Mn)

20. Company Profiles
20.1. Genesis Genetics (CooperSurgical; Inc.)
20.1.1. Company Overview
20.1.2. Products/Services Portfolio
20.1.3. Geographical Presence
20.1.4. Financial Summary
20.1.4.1. Market Revenue and Net Profit (2019-2022)
20.1.4.2. Business Segment Revenue Analysis
20.1.4.3. Geographical Revenue Analysis
20.2. Natera, Inc
20.3. Centogene N.V
20.4. Illumina, Inc. (Verinata Health, Inc.)
20.5. Eurofins LifeCodexx GmbH
20.6. MedGenome Labs Ltd
20.7. F. Hoffmann-La Roche Ltd. (Ariosa Diagnostics)
20.8. Myriad Women’s Health, Inc. (Counsyl; Inc.)
20.9. QIAGEN
20.10. Laboratory Corp. of America Holdings
20.11. Progenity, Inc
20.12. Quest Diagnostics, Inc.

List of Figures
FIG. 1 Global Non-Invasive Prenatal Testing Market: Research Methodology
FIG. 2 Market Size Estimation – Top Down & Bottom up Approach
FIG. 3 Global Non-Invasive Prenatal Testing Market Segment
FIG. 4 Global Non-Invasive Prenatal Testing Market, by Gestation Period, 2022 (US$ Mn)
FIG. 5 Global Non-Invasive Prenatal Testing Market, by Pregnancy Risk, 2022 (US$ Mn)
FIG. 6 Global Non-Invasive Prenatal Testing Market, by Method, 2022 (US$ Mn)
FIG. 7 Global Non-Invasive Prenatal Testing Market, by Technology, 2022 (US$ Mn)
FIG. 8 Global Non-Invasive Prenatal Testing Market, by Application, 2022 (US$ Mn)
FIG. 9 Global Non-Invasive Prenatal Testing Market, by Products, 2022 (US$ Mn)
FIG. 10 Global Non-Invasive Prenatal Testing Market, by End User, 2022 (US$ Mn)
FIG. 11 Global Non-Invasive Prenatal Testing Market, by Geography, 2022 (US$ Mn)
FIG. 12 Attractive Investment Proposition, by Gestation Period, 2022
FIG. 13 Attractive Investment Proposition, by Pregnancy Risk, 2022
FIG. 14 Attractive Investment Proposition, by Method, 2022
FIG. 15 Attractive Investment Proposition, by Technology, 2022
FIG. 16 Attractive Investment Proposition, by Application, 2022
FIG. 17 Attractive Investment Proposition, by Products, 2022
FIG. 18 Attractive Investment Proposition, by End User, 2022
FIG. 19 Attractive Investment Proposition, by Geography, 2022
FIG. 20 Global Market Share Analysis of Key Non-Invasive Prenatal Testing Market Manufacturers, 2022
FIG. 21 Global Market Positioning of Key Non-Invasive Prenatal Testing Market Manufacturers, 2022
FIG. 22 Global Non-Invasive Prenatal Testing Market Value Contribution, By Gestation Period, 2022 & 2030 (Value %)
FIG. 23 Global Non-Invasive Prenatal Testing Market, by 0-12 Weeks, Value, 2017-2030 (US$ Mn)
FIG. 24 Global Non-Invasive Prenatal Testing Market, by 13-24 Weeks, Value, 2017-2030 (US$ Mn)
FIG. 25 Global Non-Invasive Prenatal Testing Market, by 25-36 Weeks, Value, 2017-2030 (US$ Mn)
FIG. 26 Global Non-Invasive Prenatal Testing Market Value Contribution, By Pregnancy Risk, 2022 & 2030 (Value %)
FIG. 27 Global Non-Invasive Prenatal Testing Market, by High & Average Risk, Value, 2017-2030 (US$ Mn)
FIG. 28 Global Non-Invasive Prenatal Testing Market, by Low Risk, 2017-2030 (US$ Mn)
FIG. 29 Global Non-Invasive Prenatal Testing Market Value Contribution, By Method, 2022 & 2030 (Value %)
FIG. 30 Global Non-Invasive Prenatal Testing Market, by Ultrasound Detection, Value, 2017-2030 (US$ Mn)
FIG. 31 Global Non-Invasive Prenatal Testing Market, by Biochemical Screening Tests, 2017-2030 (US$ Mn)
FIG. 32 Global Non-Invasive Prenatal Testing Market, by Cell-free DNA in Maternal Plasma Tests, 2017-2030 (US$ Mn)
FIG. 33 Global Non-Invasive Prenatal Testing Market Value Contribution, By Technology, 2022 & 2030 (Value %)
FIG. 34 Global Non-Invasive Prenatal Testing Market, by NGS, Value, 2017-2030 (US$ Mn)
FIG. 35 Global Non-Invasive Prenatal Testing Market, by Array Technology, 2017-2030 (US$ Mn)
FIG. 36 Global Non-Invasive Prenatal Testing Market, by PCR, 2017-2030 (US$ Mn)
FIG. 37 Global Non-Invasive Prenatal Testing Market, by Others, Value, 2017-2030 (US$ Mn)
FIG. 38 Global Non-Invasive Prenatal Testing Market Value Contribution, By Application, 2022 & 2030 (Value %)
FIG. 39 Global Non-Invasive Prenatal Testing Market, by Trisomy, 2017-2030 (US$ Mn)
FIG. 40 Global Non-Invasive Prenatal Testing Market, by Microdeletion Syndrome, 2017-2030 (US$ Mn)
FIG. 41 Global Non-Invasive Prenatal Testing Market, by Other Applications, 2017-2030 (US$ Mn)
FIG. 42 Global Non-Invasive Prenatal Testing Market Value Contribution, By Products, 2022 & 2030 (Value %)
FIG. 43 Global Non-Invasive Prenatal Testing Market Value Contribution, By End User, 2022 & 2030 (Value %)
FIG. 44 Global Non-Invasive Prenatal Testing Market, by Hospitals & Clinics, 2017-2030 (US$ Mn)
FIG. 45 Global Non-Invasive Prenatal Testing Market, by Diagnostic Laboratories, 2017-2030 (US$ Mn)
FIG. 46 North America Non-Invasive Prenatal Testing Market, 2017-2030 (US$ Mn)
FIG. 47 North America Non-Invasive Prenatal Testing Market, 2017-2030 (US$ Mn)
FIG. 48 U.S. Non-Invasive Prenatal Testing Market, 2017-2030 (US$ Mn)
FIG. 49 Canada Non-Invasive Prenatal Testing Market, 2017-2030 (US$ Mn)
FIG. 50 Europe Non-Invasive Prenatal Testing Market, 2017-2030 (US$ Mn)
FIG. 51 Germany Non-Invasive Prenatal Testing Market, 2017-2030 (US$ Mn)
FIG. 52 France Non-Invasive Prenatal Testing Market, 2017-2030 (US$ Mn)
FIG. 53 U.K. Non-Invasive Prenatal Testing Market, 2017-2030 (US$ Mn)
FIG. 54 Italy Non-Invasive Prenatal Testing Market, 2017-2030 (US$ Mn)
FIG. 55 Spain Non-Invasive Prenatal Testing Market, 2017-2030 (US$ Mn)
FIG. 56 Rest of Europe Non-Invasive Prenatal Testing Market, 2017-2030 (US$ Mn)
FIG. 57 Asia Pacific Non-Invasive Prenatal Testing Market, 2017-2030 (US$ Mn)
FIG. 58 China Non-Invasive Prenatal Testing Market, 2017-2030 (US$ Mn)
FIG. 59 Japan Non-Invasive Prenatal Testing Market, 2017-2030 (US$ Mn)
FIG. 60 India Non-Invasive Prenatal Testing Market, 2017-2030 (US$ Mn)
FIG. 61 South Korea Non-Invasive Prenatal Testing Market, 2017-2030 (US$ Mn)
FIG. 62 South-East Asia Non-Invasive Prenatal Testing Market, 2017-2030 (US$ Mn)
FIG. 63 Rest of Asia Pacific Non-Invasive Prenatal Testing Market, 2017-2030 (US$ Mn)
FIG. 64 Latin America Non-Invasive Prenatal Testing Market, 2017-2030 (US$ Mn)
FIG. 65 Brazil Non-Invasive Prenatal Testing Market, 2017-2030 (US$ Mn)
FIG. 66 Mexico Non-Invasive Prenatal Testing Market, 2017-2030 (US$ Mn)
FIG. 67 Rest of Latin America Non-Invasive Prenatal Testing Market, 2017-2030 (US$ Mn)
FIG. 68 Middle East & Africa Non-Invasive Prenatal Testing Market, 2017-2030 (US$ Mn)
FIG. 69 GCC Countries Non-Invasive Prenatal Testing Market, 2017-2030 (US$ Mn)
FIG. 70 South Africa Non-Invasive Prenatal Testing Market, 2017-2030 (US$ Mn)
FIG. 71 Rest of Middle East and Africa Non-Invasive Prenatal Testing Market, 2017-2030 (US$ Mn)

List of Tables
TABLE 1 Market Snapshot: Global Non-Invasive Prenatal Testing Market
TABLE 2 Global Non-Invasive Prenatal Testing Market: Market Drivers Impact Analysis
TABLE 3 Global Non-Invasive Prenatal Testing Market: Market Restraints Impact Analysis
TABLE 4 Global Non-Invasive Prenatal Testing Market, by Competitive Benchmarking, 2022
TABLE 5 Global Non-Invasive Prenatal Testing Market, by Geographical Presence Analysis, 2022
TABLE 6 Global Non-Invasive Prenatal Testing Market, by Key Strategies Analysis, 2022
TABLE 7 Global Non-Invasive Prenatal Testing Market, by 0-12 Weeks, By Region, 2017-2022 (US$ Mn)
TABLE 8 Global Non-Invasive Prenatal Testing Market, by 0-12 Weeks, By Region, 2023-2030 (US$ Mn)
TABLE 9 Global Non-Invasive Prenatal Testing Market, by 13-24 Weeks, By Region, 2017-2022 (US$ Mn)
TABLE 10 Global Non-Invasive Prenatal Testing Market, by 13-24 Weeks, By Region, 2023-2030 (US$ Mn)
TABLE 11 Global Non-Invasive Prenatal Testing Market, by 25-36 Weeks, By Region, 2017-2022 (US$ Mn)
TABLE 12 Global Non-Invasive Prenatal Testing Market, by 25-36 Weeks, By Region, 2023-2030 (US$ Mn)
TABLE 13 Global Non-Invasive Prenatal Testing Market, by High & Average Risk, By Region, 2017-2022 (US$ Mn)
TABLE 14 Global Non-Invasive Prenatal Testing Market, by High & Average Risk, By Region, 2023-2030 (US$ Mn)
TABLE 15 Global Non-Invasive Prenatal Testing Market, by Low Risk, By Region, 2017-2022 (US$ Mn)
TABLE 16 Global Non-Invasive Prenatal Testing Market, by Low Risk, By Region, 2023-2030 (US$ Mn)
TABLE 17 Global Non-Invasive Prenatal Testing Market, by Sequencing, By Region, 2017-2022 (US$ Mn)
TABLE 18 Global Non-Invasive Prenatal Testing Market, by NGS, By Region, 2017-2022 (US$ Mn)
TABLE 19 Global Non-Invasive Prenatal Testing Market, by NGS, By Region, 2023-2030 (US$ Mn)
TABLE 20 Global Non-Invasive Prenatal Testing Market, by PCR, By Region, 2017-2022 (US$ Mn)
TABLE 21 Global Non-Invasive Prenatal Testing Market, by PCR, By Region, 2023-2030 (US$ Mn)
TABLE 22 Global Non-Invasive Prenatal Testing Market, by Others, By Region, 2017-2022 (US$ Mn)
TABLE 23 Global Non-Invasive Prenatal Testing Market, by Others, By Region, 2023-2030 (US$ Mn)
TABLE 24 Global Non-Invasive Prenatal Testing Market, by Trisomy, By Region, 2017-2022 (US$ Mn)
TABLE 25 Global Non-Invasive Prenatal Testing Market, by Trisomy, By Region, 2023-2030 (US$ Mn)
TABLE 26 Global Non-Invasive Prenatal Testing Market, by Microdeletion Syndrome, By Region, 2017-2022 (US$ Mn)
TABLE 27 Global Non-Invasive Prenatal Testing Market, by Microdeletion Syndrome, By Region, 2023-2030 (US$ Mn)
TABLE 28 Global Non-Invasive Prenatal Testing Market, by Other Applications, By Region, 2017-2022 (US$ Mn)
TABLE 29 Global Non-Invasive Prenatal Testing Market, by Other Applications, By Region, 2023-2030 (US$ Mn)
TABLE 30 Global Non-Invasive Prenatal Testing Market, by Others, By Region, 2017-2022 (US$ Mn)
TABLE 31 Global Non-Invasive Prenatal Testing Market, by Others, By Region, 2023-2030 (US$ Mn)
TABLE 32 Global Non-Invasive Prenatal Testing Market, by Instruments, By Region, 2017-2022 (US$ Mn)
TABLE 33 Global Non-Invasive Prenatal Testing Market, by Instruments, By Region, 2023-2030 (US$ Mn)
TABLE 34 Global Non-Invasive Prenatal Testing Market, by Hospitals & Clinics, By Region, 2017-2022 (US$ Mn)
TABLE 35 Global Non-Invasive Prenatal Testing Market, by Hospitals & Clinics, By Region, 2023-2030 (US$ Mn)
TABLE 36 Global Non-Invasive Prenatal Testing Market, by Diagnostic Laboratories, By Region, 2017-2022 (US$ Mn)
TABLE 37 Global Non-Invasive Prenatal Testing Market, by Diagnostic Laboratories, By Region, 2023-2030 (US$ Mn)
TABLE 38 Global Non-Invasive Prenatal Testing Market, by Region, 2017-2022 (US$ Mn)
TABLE 39 Global Non-Invasive Prenatal Testing Market, by Region, 2023-2030 (US$ Mn)
TABLE 40 North America Non-Invasive Prenatal Testing Market, by Gestation Period, 2017-2022 (US$ Mn)
TABLE 41 North America Non-Invasive Prenatal Testing Market, by Gestation Period, 2023-2030 (US$ Mn)
TABLE 42 North America Non-Invasive Prenatal Testing Market, by Pregnancy Risk, 2017-2022 (US$ Mn)
TABLE 43 North America Non-Invasive Prenatal Testing Market, by Pregnancy Risk, 2023-2030 (US$ Mn)
TABLE 44 North America Non-Invasive Prenatal Testing Market, by Method, 2017-2022 (US$ Mn)
TABLE 45 North America Non-Invasive Prenatal Testing Market, by Method, 2023-2030 (US$ Mn)
TABLE 46 North America Non-Invasive Prenatal Testing Market, by Technology, 2017-2022 (US$ Mn)
TABLE 47 North America Non-Invasive Prenatal Testing Market, by Technology, 2023-2030 (US$ Mn)
TABLE 48 North America Non-Invasive Prenatal Testing Market, by Application, 2017-2022 (US$ Mn)
TABLE 49 North America Non-Invasive Prenatal Testing Market, by Application, 2023-2030 (US$ Mn)
TABLE 50 North America Non-Invasive Prenatal Testing Market, by Products, 2017-2022 (US$ Mn)
TABLE 51 North America Non-Invasive Prenatal Testing Market, by Products, 2023-2030 (US$ Mn)
TABLE 52 North America Non-Invasive Prenatal Testing Market, by End User, 2017-2022 (US$ Mn)
TABLE 53 North America Non-Invasive Prenatal Testing Market, by End User, 2023-2030 (US$ Mn)
TABLE 54 North America Non-Invasive Prenatal Testing Market, by Country, 2017-2022 (US$ Mn)
TABLE 55 North America Non-Invasive Prenatal Testing Market, by Country, 2023-2030 (US$ Mn)
TABLE 56 United States Non-Invasive Prenatal Testing Market, by Gestation Period, 2017-2022 (US$ Mn)
TABLE 57 United States Non-Invasive Prenatal Testing Market, by Gestation Period, 2023-2030 (US$ Mn)
TABLE 58 United States Non-Invasive Prenatal Testing Market, by Pregnancy Risk, 2017-2022 (US$ Mn)
TABLE 59 United States Non-Invasive Prenatal Testing Market, by Pregnancy Risk, 2023-2030 (US$ Mn)
TABLE 60 United States Non-Invasive Prenatal Testing Market, by Method, 2017-2022 (US$ Mn)
TABLE 61 United States Non-Invasive Prenatal Testing Market, by Method, 2023-2030 (US$ Mn)
TABLE 62 United States Non-Invasive Prenatal Testing Market, by Technology, 2017-2022 (US$ Mn)
TABLE 63 United States Non-Invasive Prenatal Testing Market, by Technology, 2023-2030 (US$ Mn)
TABLE 64 United States Non-Invasive Prenatal Testing Market, by Application, 2017-2022 (US$ Mn)
TABLE 65 United States Non-Invasive Prenatal Testing Market, by Application, 2023-2030 (US$ Mn)
TABLE 66 United States Non-Invasive Prenatal Testing Market, by Products, 2017-2022 (US$ Mn)
TABLE 67 United States Non-Invasive Prenatal Testing Market, by Products, 2023-2030 (US$ Mn)
TABLE 68 United States Non-Invasive Prenatal Testing Market, by End User, 2017-2022 (US$ Mn)
TABLE 69 United States Non-Invasive Prenatal Testing Market, by End User, 2023-2030 (US$ Mn)
TABLE 70 Canada Non-Invasive Prenatal Testing Market, by Gestation Period, 2017-2022 (US$ Mn)
TABLE 71 Canada Non-Invasive Prenatal Testing Market, by Gestation Period, 2023-2030 (US$ Mn)
TABLE 72 Canada Non-Invasive Prenatal Testing Market, by Pregnancy Risk, 2017-2022 (US$ Mn)
TABLE 73 Canada Non-Invasive Prenatal Testing Market, by Pregnancy Risk, 2023-2030 (US$ Mn)
TABLE 74 Canada Non-Invasive Prenatal Testing Market, by Technology, 2017-2022 (US$ Mn)
TABLE 75 Canada Non-Invasive Prenatal Testing Market, by Technology, 2023-2030 (US$ Mn)
TABLE 76 Canada Non-Invasive Prenatal Testing Market, by Application, 2017-2022 (US$ Mn)
TABLE 77 Canada Non-Invasive Prenatal Testing Market, by Application, 2023-2030 (US$ Mn)
TABLE 78 Canada Non-Invasive Prenatal Testing Market, by Products, 2017-2022 (US$ Mn)
TABLE 79 Canada Non-Invasive Prenatal Testing Market, by Products, 2023-2030 (US$ Mn)
TABLE 80 Canada Non-Invasive Prenatal Testing Market, by End User, 2017-2022 (US$ Mn)
TABLE 81 Canada Non-Invasive Prenatal Testing Market, by End User, 2023-2030 (US$ Mn)
TABLE 82 Mexico Non-Invasive Prenatal Testing Market, by Gestation Period, 2017-2022 (US$ Mn)
TABLE 83 Mexico Non-Invasive Prenatal Testing Market, by Gestation Period, 2023-2030 (US$ Mn)
TABLE 84 Mexico Non-Invasive Prenatal Testing Market, by Pregnancy Risk, 2017-2022 (US$ Mn)
TABLE 85 Mexico Non-Invasive Prenatal Testing Market, by Pregnancy Risk, 2023-2030 (US$ Mn)
TABLE 86 Mexico Non-Invasive Prenatal Testing Market, by Technology, 2017-2022 (US$ Mn)
TABLE 87 Mexico Non-Invasive Prenatal Testing Market, by Technology, 2023-2030 (US$ Mn)
TABLE 88 Mexico Non-Invasive Prenatal Testing Market, by Application, 2017-2022 (US$ Mn)
TABLE 89 Mexico Non-Invasive Prenatal Testing Market, by Application, 2023-2030 (US$ Mn)
TABLE 90 Mexico Non-Invasive Prenatal Testing Market, by Products, 2017-2022 (US$ Mn)
TABLE 91 Mexico Non-Invasive Prenatal Testing Market, by Products, 2023-2030 (US$ Mn)
TABLE 92 Mexico Non-Invasive Prenatal Testing Market, by End User, 2017-2022 (US$ Mn)
TABLE 93 Mexico Non-Invasive Prenatal Testing Market, by End User, 2023-2030 (US$ Mn)
TABLE 94 Europe Non-Invasive Prenatal Testing Market, by Gestation Period, 2017-2022 (US$ Mn)
TABLE 95 Europe Non-Invasive Prenatal Testing Market, by Gestation Period, 2023-2030 (US$ Mn)
TABLE 96 Europe Non-Invasive Prenatal Testing Market, by Pregnancy Risk, 2017-2022 (US$ Mn)
TABLE 97 Europe Non-Invasive Prenatal Testing Market, by Pregnancy Risk, 2023-2030 (US$ Mn)
TABLE 98 Europe Non-Invasive Prenatal Testing Market, by Method, 2017-2022 (US$ Mn)
TABLE 99 Europe Non-Invasive Prenatal Testing Market, by Method, 2023-2030 (US$ Mn)
TABLE 100 Europe Non-Invasive Prenatal Testing Market, by Technology, 2017-2022 (US$ Mn)
TABLE 101 Europe Non-Invasive Prenatal Testing Market, by Technology, 2023-2030 (US$ Mn)
TABLE 102 Europe Non-Invasive Prenatal Testing Market, by Application, 2017-2022 (US$ Mn)
TABLE 103 Europe Non-Invasive Prenatal Testing Market, by Application, 2023-2030 (US$ Mn)
TABLE 104 Europe Non-Invasive Prenatal Testing Market, by Products, 2017-2022 (US$ Mn)
TABLE 105 Europe Non-Invasive Prenatal Testing Market, by Products, 2023-2030 (US$ Mn)
TABLE 106 Europe Non-Invasive Prenatal Testing Market, by End User, 2017-2022 (US$ Mn)
TABLE 107 Europe Non-Invasive Prenatal Testing Market, by End User, 2023-2030 (US$ Mn)
TABLE 108 Europe Non-Invasive Prenatal Testing Market, by Country, 2017-2022 (US$ Mn)
TABLE 109 Europe Non-Invasive Prenatal Testing Market, by Country, 2023-2030 (US$ Mn)
TABLE 110 Germany Non-Invasive Prenatal Testing Market, by Gestation Period, 2017-2022 (US$ Mn)
TABLE 111 Germany Non-Invasive Prenatal Testing Market, by Gestation Period, 2023-2030 (US$ Mn)
TABLE 112 Germany Non-Invasive Prenatal Testing Market, by Pregnancy Risk, 2017-2022 (US$ Mn)
TABLE 113 Germany Non-Invasive Prenatal Testing Market, by Pregnancy Risk, 2023-2030 (US$ Mn)
TABLE 114 Germany Non-Invasive Prenatal Testing Market, by Method, 2017-2022 (US$ Mn)
TABLE 115 Germany Non-Invasive Prenatal Testing Market, by Method, 2023-2030 (US$ Mn)
TABLE 116 Germany Non-Invasive Prenatal Testing Market, by Technology, 2017-2022 (US$ Mn)
TABLE 117 Germany Non-Invasive Prenatal Testing Market, by Technology, 2023-2030 (US$ Mn)
TABLE 118 Germany Non-Invasive Prenatal Testing Market, by Application, 2017-2022 (US$ Mn)
TABLE 119 Germany Non-Invasive Prenatal Testing Market, by Application, 2023-2030 (US$ Mn)
TABLE 120 Germany Non-Invasive Prenatal Testing Market, by Products, 2017-2022 (US$ Mn)
TABLE 121 Germany Non-Invasive Prenatal Testing Market, by Products, 2023-2030 (US$ Mn)
TABLE 122 Germany Non-Invasive Prenatal Testing Market, by End User, 2017-2022 (US$ Mn)
TABLE 123 Germany Non-Invasive Prenatal Testing Market, by End User, 2023-2030 (US$ Mn)
TABLE 124 France Non-Invasive Prenatal Testing Market, by Gestation Period, 2017-2022 (US$ Mn)
TABLE 125 France Non-Invasive Prenatal Testing Market, by Gestation Period, 2023-2030 (US$ Mn)
TABLE 126 France Non-Invasive Prenatal Testing Market, by Pregnancy Risk, 2017-2022 (US$ Mn)
TABLE 127 France Non-Invasive Prenatal Testing Market, by Pregnancy Risk, 2023-2030 (US$ Mn)
TABLE 128 France Non-Invasive Prenatal Testing Market, by Method, 2017-2022 (US$ Mn)
TABLE 129 France Non-Invasive Prenatal Testing Market, by Method, 2023-2030 (US$ Mn)
TABLE 130 France Non-Invasive Prenatal Testing Market, by Technology, 2017-2022 (US$ Mn)
TABLE 131 France Non-Invasive Prenatal Testing Market, by Technology, 2023-2030 (US$ Mn)
TABLE 132 France Non-Invasive Prenatal Testing Market, by Application, 2017-2022 (US$ Mn)
TABLE 133 France Non-Invasive Prenatal Testing Market, by Application, 2023-2030 (US$ Mn)
TABLE 134 France Non-Invasive Prenatal Testing Market, by Products, 2017-2022 (US$ Mn)
TABLE 135 France Non-Invasive Prenatal Testing Market, by Products, 2023-2030 (US$ Mn)
TABLE 136 France Non-Invasive Prenatal Testing Market, by End User, 2017-2022 (US$ Mn)
TABLE 137 France Non-Invasive Prenatal Testing Market, by End User, 2023-2030 (US$ Mn)
TABLE 138 United Kingdom Non-Invasive Prenatal Testing Market, by Gestation Period, 2017-2022 (US$ Mn)
TABLE 139 United Kingdom Non-Invasive Prenatal Testing Market, by Gestation Period, 2023-2030 (US$ Mn)
TABLE 140 United Kingdom Non-Invasive Prenatal Testing Market, by Pregnancy Risk, 2017-2022 (US$ Mn)
TABLE 141 United Kingdom Non-Invasive Prenatal Testing Market, by Pregnancy Risk, 2023-2030 (US$ Mn)
TABLE 142 United Kingdom Non-Invasive Prenatal Testing Market, by Method, 2017-2022 (US$ Mn)
TABLE 143 United Kingdom Non-Invasive Prenatal Testing Market, by Method, 2023-2030 (US$ Mn)
TABLE 144 United Kingdom Non-Invasive Prenatal Testing Market, by Technology, 2017-2022 (US$ Mn)
TABLE 145 United Kingdom Non-Invasive Prenatal Testing Market, by Technology, 2023-2030 (US$ Mn)
TABLE 146 United Kingdom Non-Invasive Prenatal Testing Market, by Application, 2017-2022 (US$ Mn)
TABLE 147 United Kingdom Non-Invasive Prenatal Testing Market, by Application, 2023-2030 (US$ Mn)
TABLE 148 United Kingdom Non-Invasive Prenatal Testing Market, by Products, 2017-2022 (US$ Mn)
TABLE 149 United Kingdom Non-Invasive Prenatal Testing Market, by Products, 2023-2030 (US$ Mn)
TABLE 150 United Kingdom Non-Invasive Prenatal Testing Market, by End User, 2017-2022 (US$ Mn)
TABLE 151 United Kingdom Non-Invasive Prenatal Testing Market, by End User, 2023-2030 (US$ Mn)
TABLE 152 Italy Non-Invasive Prenatal Testing Market, by Gestation Period, 2017-2022 (US$ Mn)
TABLE 153 Italy Non-Invasive Prenatal Testing Market, by Gestation Period, 2023-2030 (US$ Mn)
TABLE 154 Italy Non-Invasive Prenatal Testing Market, by Pregnancy Risk, 2017-2022 (US$ Mn)
TABLE 155 Italy Non-Invasive Prenatal Testing Market, by Pregnancy Risk, 2023-2030 (US$ Mn)
TABLE 156 Italy Non-Invasive Prenatal Testing Market, by Method, 2017-2022 (US$ Mn)
TABLE 157 Italy Non-Invasive Prenatal Testing Market, by Method, 2023-2030 (US$ Mn)
TABLE 158 Italy Non-Invasive Prenatal Testing Market, by Technology, 2017-2022 (US$ Mn)
TABLE 159 Italy Non-Invasive Prenatal Testing Market, by Technology, 2023-2030 (US$ Mn)
TABLE 160 Italy Non-Invasive Prenatal Testing Market, by Application, 2017-2022 (US$ Mn)
TABLE 161 Italy Non-Invasive Prenatal Testing Market, by Application, 2023-2030 (US$ Mn)
TABLE 162 Italy Non-Invasive Prenatal Testing Market, by Products, 2017-2022 (US$ Mn)
TABLE 163 Italy Non-Invasive Prenatal Testing Market, by Products, 2023-2030 (US$ Mn)
TABLE 164 Italy Non-Invasive Prenatal Testing Market, by End User, 2017-2022 (US$ Mn)
TABLE 165 Italy Non-Invasive Prenatal Testing Market, by End User, 2023-2030 (US$ Mn)
TABLE 166 Spain Non-Invasive Prenatal Testing Market, by Gestation Period, 2017-2022 (US$ Mn)
TABLE 167 Spain Non-Invasive Prenatal Testing Market, by Gestation Period, 2023-2030 (US$ Mn)
TABLE 168 Spain Non-Invasive Prenatal Testing Market, by Pregnancy Risk, 2017-2022 (US$ Mn)
TABLE 169 Spain Non-Invasive Prenatal Testing Market, by Pregnancy Risk, 2023-2030 (US$ Mn)
TABLE 170 Spain Non-Invasive Prenatal Testing Market, by Method, 2017-2022 (US$ Mn)
TABLE 171 Spain Non-Invasive Prenatal Testing Market, by Method, 2023-2030 (US$ Mn)
TABLE 172 Spain Non-Invasive Prenatal Testing Market, by Technology, 2017-2022 (US$ Mn)
TABLE 173 Spain Non-Invasive Prenatal Testing Market, by Technology, 2023-2030 (US$ Mn)
TABLE 174 Spain Non-Invasive Prenatal Testing Market, by Gestation Period, 2017-2022 (US$ Mn)
TABLE 175 Spain Non-Invasive Prenatal Testing Market, by Application, 2023-2030 (US$ Mn)
TABLE 176 Spain Non-Invasive Prenatal Testing Market, by Application, 2017-2022 (US$ Mn)
TABLE 177 Spain Non-Invasive Prenatal Testing Market, by Products, 2023-2030 (US$ Mn)
TABLE 178 Spain Non-Invasive Prenatal Testing Market, by End User, 2017-2022 (US$ Mn)
TABLE 179 Spain Non-Invasive Prenatal Testing Market, by End User, 2023-2030 (US$ Mn)
TABLE 180 Rest of Europe Non-Invasive Prenatal Testing Market, by Gestation Period, 2017-2022 (US$ Mn)
TABLE 181 Rest of Europe Non-Invasive Prenatal Testing Market, by Gestation Period, 2023-2030 (US$ Mn)
TABLE 182 Rest of Europe Non-Invasive Prenatal Testing Market, by Pregnancy Risk, 2017-2022 (US$ Mn)
TABLE 183 Rest of Europe Non-Invasive Prenatal Testing Market, by Pregnancy Risk, 2023-2030 (US$ Mn)
TABLE 184 Rest of Europe Non-Invasive Prenatal Testing Market, by Method, 2017-2022 (US$ Mn)
TABLE 185 Rest of Europe Non-Invasive Prenatal Testing Market, by Method, 2023-2030 (US$ Mn)
TABLE 186 Rest of Europe Non-Invasive Prenatal Testing Market, by Technology, 2017-2022 (US$ Mn)
TABLE 187 Rest of Europe Non-Invasive Prenatal Testing Market, by Technology, 2023-2030 (US$ Mn)
TABLE 188 Rest of Europe Non-Invasive Prenatal Testing Market, by Application, 2017-2022 (US$ Mn)
TABLE 189 Rest of Europe Non-Invasive Prenatal Testing Market, by Application, 2023-2030 (US$ Mn)
TABLE 190 Rest of Europe Non-Invasive Prenatal Testing Market, by Products, 2017-2022 (US$ Mn)
TABLE 191 Rest of Europe Non-Invasive Prenatal Testing Market, by Products, 2023-2030 (US$ Mn)
TABLE 192 Rest of Europe Non-Invasive Prenatal Testing Market, by End User, 2017-2022 (US$ Mn)
TABLE 193 Rest of Europe Non-Invasive Prenatal Testing Market, by End User, 2023-2030 (US$ Mn)
TABLE 194 Asia Pacific Non-Invasive Prenatal Testing Market, by Gestation Period, 2017-2022 (US$ Mn)
TABLE 195 Asia Pacific Non-Invasive Prenatal Testing Market, by Gestation Period, 2023-2030 (US$ Mn)
TABLE 196 Asia Pacific Non-Invasive Prenatal Testing Market, by Pregnancy Risk, 2017-2022 (US$ Mn)
TABLE 197 Asia Pacific Non-Invasive Prenatal Testing Market, by Pregnancy Risk, 2023-2030 (US$ Mn)
TABLE 198 Asia Pacific Non-Invasive Prenatal Testing Market, by Method, 2017-2022 (US$ Mn)
TABLE 199 Asia Pacific Non-Invasive Prenatal Testing Market, by Method, 2023-2030 (US$ Mn)
TABLE 200 Asia Pacific Non-Invasive Prenatal Testing Market, by Technology, 2017-2022 (US$ Mn)
TABLE 201 Asia Pacific Non-Invasive Prenatal Testing Market, by Technology, 2023-2030 (US$ Mn)
TABLE 202 Asia Pacific Non-Invasive Prenatal Testing Market, by Application, 2017-2022 (US$ Mn)
TABLE 203 Asia Pacific Non-Invasive Prenatal Testing Market, by Application, 2023-2030 (US$ Mn)
TABLE 204 Asia Pacific Non-Invasive Prenatal Testing Market, by Products, 2017-2022 (US$ Mn)
TABLE 205 Asia Pacific Non-Invasive Prenatal Testing Market, by Products, 2023-2030 (US$ Mn)
TABLE 206 Asia Pacific Non-Invasive Prenatal Testing Market, by End User, 2017-2022 (US$ Mn)
TABLE 207 Asia Pacific Non-Invasive Prenatal Testing Market, by End User, 2023-2030 (US$ Mn)
TABLE 208 China Non-Invasive Prenatal Testing Market, by Gestation Period, 2017-2022 (US$ Mn)
TABLE 209 China Non-Invasive Prenatal Testing Market, by Gestation Period, 2023-2030 (US$ Mn)
TABLE 210 China Non-Invasive Prenatal Testing Market, by Pregnancy Risk, 2017-2022 (US$ Mn)
TABLE 211 China Non-Invasive Prenatal Testing Market, by Pregnancy Risk, 2023-2030 (US$ Mn)
TABLE 212 China Non-Invasive Prenatal Testing Market, by Method, 2017-2022 (US$ Mn)
TABLE 213 China Non-Invasive Prenatal Testing Market, by Method, 2023-2030 (US$ Mn)
TABLE 214 China Non-Invasive Prenatal Testing Market, by Technology, 2017-2022 (US$ Mn)
TABLE 215 China Non-Invasive Prenatal Testing Market, by Technology, 2023-2030 (US$ Mn)
TABLE 216 China Non-Invasive Prenatal Testing Market, by Application, 2017-2022 (US$ Mn)
TABLE 217 China Non-Invasive Prenatal Testing Market, by Application, 2023-2030 (US$ Mn)
TABLE 218 China Non-Invasive Prenatal Testing Market, by Products, 2017-2022 (US$ Mn)
TABLE 219 China Non-Invasive Prenatal Testing Market, by Products, 2023-2030 (US$ Mn)

TABLE 220 China Non-Invasive Prenatal Testing Market, by End User, 2017-2022 (US$ Mn)
TABLE 221 China Non-Invasive Prenatal Testing Market, by End User, 2023-2030 (US$ Mn)
TABLE 222 Japan Non-Invasive Prenatal Testing Market, by Gestation Period, 2017-2022 (US$ Mn)
TABLE 223 Japan Non-Invasive Prenatal Testing Market, by Gestation Period, 2023-2030 (US$ Mn)
TABLE 224 Japan Non-Invasive Prenatal Testing Market, by Pregnancy Risk, 2017-2022 (US$ Mn)
TABLE 225 Japan Non-Invasive Prenatal Testing Market, by Pregnancy Risk, 2023-2030 (US$ Mn)
TABLE 226 Japan Non-Invasive Prenatal Testing Market, by Method, 2017-2022 (US$ Mn)
TABLE 227 Japan Non-Invasive Prenatal Testing Market, by Method, 2023-2030 (US$ Mn)
TABLE 228 Japan Non-Invasive Prenatal Testing Market, by Technology, 2017-2022 (US$ Mn)
TABLE 229 Japan Non-Invasive Prenatal Testing Market, by Technology, 2023-2030 (US$ Mn)
TABLE 230 Japan Non-Invasive Prenatal Testing Market, by Application, 2017-2022 (US$ Mn)
TABLE 231 Japan Non-Invasive Prenatal Testing Market, by Application, 2023-2030 (US$ Mn)
TABLE 232 Japan Non-Invasive Prenatal Testing Market, by Products, 2017-2022 (US$ Mn)
TABLE 233 Japan Non-Invasive Prenatal Testing Market, by Products, 2023-2030 (US$ Mn)
TABLE 234 Japan Non-Invasive Prenatal Testing Market, by End User, 2017-2022 (US$ Mn)
TABLE 235 Japan Non-Invasive Prenatal Testing Market, by End User, 2023-2030 (US$ Mn)
TABLE 236 India Non-Invasive Prenatal Testing Market, by Gestation Period, 2017-2022 (US$ Mn)
TABLE 237 India Non-Invasive Prenatal Testing Market, by Gestation Period, 2023-2030 (US$ Mn)
TABLE 238 India Non-Invasive Prenatal Testing Market, by Pregnancy Risk, 2017-2022 (US$ Mn)
TABLE 239 India Non-Invasive Prenatal Testing Market, by Pregnancy Risk, 2023-2030 (US$ Mn)
TABLE 240 India Non-Invasive Prenatal Testing Market, by Method, 2017-2022 (US$ Mn)
TABLE 241 India Non-Invasive Prenatal Testing Market, by Method, 2023-2030 (US$ Mn)
TABLE 242 India Non-Invasive Prenatal Testing Market, by Technology, 2017-2022 (US$ Mn)
TABLE 243 India Non-Invasive Prenatal Testing Market, by Technology, 2023-2030 (US$ Mn)
TABLE 244 India Non-Invasive Prenatal Testing Market, by Application, 2017-2022 (US$ Mn)
TABLE 245 India Non-Invasive Prenatal Testing Market, by Application, 2023-2030 (US$ Mn)
TABLE 246 India Non-Invasive Prenatal Testing Market, by Products, 2017-2022 (US$ Mn)
TABLE 247 India Non-Invasive Prenatal Testing Market, by Products, 2023-2030 (US$ Mn)
TABLE 248 India Non-Invasive Prenatal Testing Market, by End User, 2017-2022 (US$ Mn)
TABLE 249 India Non-Invasive Prenatal Testing Market, by End User, 2023-2030 (US$ Mn)
TABLE 250 South Korea Non-Invasive Prenatal Testing Market, by Gestation Period, 2017-2022 (US$ Mn)
TABLE 251 South Korea Non-Invasive Prenatal Testing Market, by Gestation Period, 2023-2030 (US$ Mn)
TABLE 252 South Korea Non-Invasive Prenatal Testing Market, by Pregnancy Risk, 2017-2022 (US$ Mn)
TABLE 253 South Korea Non-Invasive Prenatal Testing Market, by Pregnancy Risk, 2023-2030 (US$ Mn)
TABLE 254 South Korea Non-Invasive Prenatal Testing Market, by Method, 2017-2022 (US$ Mn)
TABLE 255 South Korea Non-Invasive Prenatal Testing Market, by Method, 2023-2030 (US$ Mn)
TABLE 256 South Korea Non-Invasive Prenatal Testing Market, by Technology, 2017-2022 (US$ Mn)
TABLE 257 South Korea Non-Invasive Prenatal Testing Market, by Technology, 2023-2030 (US$ Mn)
TABLE 258 South Korea Non-Invasive Prenatal Testing Market, by Application, 2017-2022 (US$ Mn)
TABLE 259 South Korea Non-Invasive Prenatal Testing Market, by Application, 2023-2030 (US$ Mn)
TABLE 260 South Korea Non-Invasive Prenatal Testing Market, by Products, 2017-2022 (US$ Mn)
TABLE 261 South Korea Non-Invasive Prenatal Testing Market, by Products, 2023-2030 (US$ Mn)
TABLE 262 South Korea Non-Invasive Prenatal Testing Market, by End User, 2017-2022 (US$ Mn)
TABLE 263 South Korea Non-Invasive Prenatal Testing Market, by End User, 2023-2030 (US$ Mn)
TABLE 264 South-East Asia Non-Invasive Prenatal Testing Market, by Gestation Period, 2017-2022 (US$ Mn)
TABLE 265 South-East Asia Non-Invasive Prenatal Testing Market, by Gestation Period, 2023-2030 (US$ Mn)
TABLE 266 South-East Asia Non-Invasive Prenatal Testing Market, by Pregnancy Risk, 2017-2022 (US$ Mn)
TABLE 267 South-East Asia Non-Invasive Prenatal Testing Market, by Pregnancy Risk, 2023-2030 (US$ Mn)
TABLE 268 South-East Asia Non-Invasive Prenatal Testing Market, by Method, 2017-2022 (US$ Mn)
TABLE 269 South-East Asia Non-Invasive Prenatal Testing Market, by Method, 2023-2030 (US$ Mn)
TABLE 270 South-East Asia Non-Invasive Prenatal Testing Market, by Technology, 2017-2022 (US$ Mn)
TABLE 271 South-East Asia Non-Invasive Prenatal Testing Market, by Technology, 2023-2030 (US$ Mn)
TABLE 272 South-East Asia Non-Invasive Prenatal Testing Market, by Application, 2017-2022 (US$ Mn)
TABLE 273 South-East Asia Non-Invasive Prenatal Testing Market, by Application, 2023-2030 (US$ Mn)
TABLE 274 South-East Asia Non-Invasive Prenatal Testing Market, by Products, 2017-2022 (US$ Mn)
TABLE 275 South-East Asia Non-Invasive Prenatal Testing Market, by Products, 2023-2030 (US$ Mn)
TABLE 276 South-East Asia Non-Invasive Prenatal Testing Market, by End User, 2017-2022 (US$ Mn)
TABLE 277 South-East Asia Non-Invasive Prenatal Testing Market, by End User, 2023-2030 (US$ Mn)
TABLE 278 Rest of Asia Pacific Non-Invasive Prenatal Testing Market, by Gestation Period, 2017-2022 (US$ Mn)
TABLE 279 Rest of Asia Pacific Non-Invasive Prenatal Testing Market, by Gestation Period, 2023-2030 (US$ Mn)
TABLE 280 Rest of Asia Pacific Non-Invasive Prenatal Testing Market, by Pregnancy Risk, 2017-2022 (US$ Mn)
TABLE 281 Rest of Asia Pacific Non-Invasive Prenatal Testing Market, by Pregnancy Risk, 2023-2030 (US$ Mn)
TABLE 282 Rest of Asia Pacific Non-Invasive Prenatal Testing Market, by Method, 2017-2022 (US$ Mn)
TABLE 283 Rest of Asia Pacific Non-Invasive Prenatal Testing Market, by Method, 2023-2030 (US$ Mn)
TABLE 284 Rest of Asia Pacific Non-Invasive Prenatal Testing Market, by Technology, 2017-2022 (US$ Mn)
TABLE 285 Rest of Asia Pacific Non-Invasive Prenatal Testing Market, by Technology, 2023-2030 (US$ Mn)
TABLE 286 Rest of Asia Pacific Non-Invasive Prenatal Testing Market, by Application, 2017-2022 (US$ Mn)
TABLE 287 Rest of Asia Pacific Non-Invasive Prenatal Testing Market, by Application, 2023-2030 (US$ Mn)
TABLE 288 Rest of Asia Pacific Non-Invasive Prenatal Testing Market, by Products, 2017-2022 (US$ Mn)
TABLE 289 Rest of Asia Pacific Non-Invasive Prenatal Testing Market, by Products, 2023-2030 (US$ Mn)
TABLE 290 Rest of Asia Pacific Non-Invasive Prenatal Testing Market, by End User, 2017-2022 (US$ Mn)
TABLE 291 Rest of Asia Pacific Non-Invasive Prenatal Testing Market, by End User, 2023-2030 (US$ Mn)
TABLE 292 Latin America Non-Invasive Prenatal Testing Market, by Application, 2017-2022 (US$ Mn)
TABLE 293 Latin America Non-Invasive Prenatal Testing Market, by Application, 2023-2030 (US$ Mn)
TABLE 294 Latin America Non-Invasive Prenatal Testing Market, by Products, 2017-2022 (US$ Mn)
TABLE 295 Latin America Non-Invasive Prenatal Testing Market, by Products, 2023-2030 (US$ Mn)
TABLE 296 Latin America Non-Invasive Prenatal Testing Market, by Method, 2017-2022 (US$ Mn)
TABLE 297 Latin America Non-Invasive Prenatal Testing Market, by Method, 2023-2030 (US$ Mn)
TABLE 298 Latin America Non-Invasive Prenatal Testing Market, by Technology, 2017-2022 (US$ Mn)
TABLE 299 Latin America Non-Invasive Prenatal Testing Market, by Technology, 2023-2030 (US$ Mn)
TABLE 300 Latin America Non-Invasive Prenatal Testing Market, by Application, 2017-2022 (US$ Mn)
TABLE 301 Latin America Non-Invasive Prenatal Testing Market, by Application, 2023-2030 (US$ Mn)
TABLE 302 Latin America Non-Invasive Prenatal Testing Market, by Products, 2017-2022 (US$ Mn)
TABLE 303 Latin America Non-Invasive Prenatal Testing Market, by Products, 2023-2030 (US$ Mn)
TABLE 304 Latin America Non-Invasive Prenatal Testing Market, by End User, 2017-2022 (US$ Mn)
TABLE 305 Latin America Non-Invasive Prenatal Testing Market, by End User, 2023-2030 (US$ Mn)
TABLE 306 Brazil Non-Invasive Prenatal Testing Market, by Gestation Period, 2017-2022 (US$ Mn)
TABLE 307 Brazil Non-Invasive Prenatal Testing Market, by Gestation Period, 2023-2030 (US$ Mn)
TABLE 308 Brazil Non-Invasive Prenatal Testing Market, by Pregnancy Risk, 2017-2022 (US$ Mn)
TABLE 309 Brazil Non-Invasive Prenatal Testing Market, by Pregnancy Risk, 2023-2030 (US$ Mn)
TABLE 310 Brazil Non-Invasive Prenatal Testing Market, by Method, 2017-2022 (US$ Mn)
TABLE 311 Brazil Non-Invasive Prenatal Testing Market, by Method, 2023-2030 (US$ Mn)
TABLE 312 Brazil Non-Invasive Prenatal Testing Market, by Technology, 2017-2022 (US$ Mn)
TABLE 313 Brazil Non-Invasive Prenatal Testing Market, by Technology, 2023-2030 (US$ Mn)
TABLE 314 Brazil Non-Invasive Prenatal Testing Market, by Application, 2017-2022 (US$ Mn)
TABLE 315 Brazil Non-Invasive Prenatal Testing Market, by Application, 2023-2030 (US$ Mn)
TABLE 316 Brazil Non-Invasive Prenatal Testing Market, by Products, 2017-2022 (US$ Mn)
TABLE 317 Brazil Non-Invasive Prenatal Testing Market, by Products, 2023-2030 (US$ Mn)
TABLE 318 Brazil Non-Invasive Prenatal Testing Market, by End User, 2017-2022 (US$ Mn)
TABLE 319 Brazil Non-Invasive Prenatal Testing Market, by End User, 2023-2030 (US$ Mn)
TABLE 320 Argentina Non-Invasive Prenatal Testing Market, by Gestation Period, 2017-2022 (US$ Mn)
TABLE 321 Argentina Non-Invasive Prenatal Testing Market, by Gestation Period, 2023-2030 (US$ Mn)
TABLE 322 Argentina Non-Invasive Prenatal Testing Market, by Pregnancy Risk, 2017-2022 (US$ Mn)
TABLE 323 Argentina Non-Invasive Prenatal Testing Market, by Pregnancy Risk, 2023-2030 (US$ Mn)
TABLE 324 Argentina Non-Invasive Prenatal Testing Market, by Method, 2017-2022 (US$ Mn)
TABLE 325 Argentina Non-Invasive Prenatal Testing Market, by Method, 2023-2030 (US$ Mn)
TABLE 326 Argentina Non-Invasive Prenatal Testing Market, by Technology, 2017-2022 (US$ Mn)
TABLE 327 Argentina Non-Invasive Prenatal Testing Market, by Technology, 2023-2030 (US$ Mn)
TABLE 328 Argentina Non-Invasive Prenatal Testing Market, by Application, 2017-2022 (US$ Mn)
TABLE 329 Argentina Non-Invasive Prenatal Testing Market, by Application, 2023-2030 (US$ Mn)
TABLE 330 Argentina Non-Invasive Prenatal Testing Market, by Products, 2017-2022 (US$ Mn)
TABLE 331 Argentina Non-Invasive Prenatal Testing Market, by Products, 2023-2030 (US$ Mn)
TABLE 332 Argentina Non-Invasive Prenatal Testing Market, by Indication Type, 2017-2022 (US$ Mn)
TABLE 333 Argentina Non-Invasive Prenatal Testing Market, by End User, 2023-2030 (US$ Mn)
TABLE 334 Rest of Latin America Non-Invasive Prenatal Testing Market, by Gestation Period, 2017-2022 (US$ Mn)
TABLE 335 Rest of Latin America Non-Invasive Prenatal Testing Market, by Gestation Period, 2023-2030 (US$ Mn)
TABLE 336 Rest of Latin America Non-Invasive Prenatal Testing Market, by Pregnancy Risk, 2017-2022 (US$ Mn)
TABLE 337 Rest of Latin America Non-Invasive Prenatal Testing Market, by Pregnancy Risk, 2023-2030 (US$ Mn)
TABLE 338 Rest of Latin America Non-Invasive Prenatal Testing Market, by Method, 2017-2022 (US$ Mn)
TABLE 339 Rest of Latin America Non-Invasive Prenatal Testing Market, by Method, 2023-2030 (US$ Mn)
TABLE 340 Rest of Latin America Non-Invasive Prenatal Testing Market, by Technology, 2017-2022 (US$ Mn)
TABLE 341 Rest of Latin America Non-Invasive Prenatal Testing Market, by Technology, 2023-2030 (US$ Mn)
TABLE 342 Rest of Latin America Non-Invasive Prenatal Testing Market, by Application, 2017-2022 (US$ Mn)
TABLE 343 Rest of Latin America Non-Invasive Prenatal Testing Market, by Application, 2023-2030 (US$ Mn)
TABLE 344 Rest of Latin America Non-Invasive Prenatal Testing Market, by Products, 2017-2022 (US$ Mn)
TABLE 345 Rest of Latin America Non-Invasive Prenatal Testing Market, by Products, 2023-2030 (US$ Mn)
TABLE 346 Rest of Latin America Non-Invasive Prenatal Testing Market, by End User, 2017-2022 (US$ Mn)
TABLE 347 Rest of Latin America Non-Invasive Prenatal Testing Market, by End User, 2023-2030 (US$ Mn)
TABLE 348 Middle East and Africa Non-Invasive Prenatal Testing Market, by Gestation Period, 2017-2022 (US$ Mn)
TABLE 349 Middle East and Africa Non-Invasive Prenatal Testing Market, by Gestation Period, 2023-2030 (US$ Mn)
TABLE 350 Middle East and Africa Non-Invasive Prenatal Testing Market, by Pregnancy Risk, 2017-2022 (US$ Mn)
TABLE 351 Middle East and Africa Non-Invasive Prenatal Testing Market, by Pregnancy Risk, 2023-2030 (US$ Mn)
TABLE 352 Middle East and Africa Non-Invasive Prenatal Testing Market, by Method, 2017-2022 (US$ Mn)
TABLE 353 Middle East and Africa Non-Invasive Prenatal Testing Market, by Method, 2023-2030 (US$ Mn)
TABLE 354 Middle East and Africa Non-Invasive Prenatal Testing Market, by Technology, 2017-2022 (US$ Mn)
TABLE 355 Middle East and Africa Non-Invasive Prenatal Testing Market, by Technology, 2023-2030 (US$ Mn)
TABLE 356 Middle East and Africa Non-Invasive Prenatal Testing Market, by Application, 2017-2022 (US$ Mn)
TABLE 357 Middle East and Africa Non-Invasive Prenatal Testing Market, by Application, 2023-2030 (US$ Mn)
TABLE 358 Middle East and Africa Non-Invasive Prenatal Testing Market, by Products, 2017-2022 (US$ Mn)
TABLE 359 Middle East and Africa Non-Invasive Prenatal Testing Market, by Products, 2023-2030 (US$ Mn)
TABLE 360 Middle East and Africa Non-Invasive Prenatal Testing Market, by End User, 2017-2022 (US$ Mn)
TABLE 361 Middle East and Africa Non-Invasive Prenatal Testing Market, by End User, 2023-2030 (US$ Mn)
TABLE 362 GCC Countries Non-Invasive Prenatal Testing Market, by Gestation Period, 2017-2022 (US$ Mn)
TABLE 363 GCC Countries Non-Invasive Prenatal Testing Market, by Gestation Period, 2023-2030 (US$ Mn)
TABLE 364 GCC Countries Non-Invasive Prenatal Testing Market, by Pregnancy Risk, 2017-2022 (US$ Mn)
TABLE 365 GCC Countries Non-Invasive Prenatal Testing Market, by Pregnancy Risk, 2023-2030 (US$ Mn)
TABLE 366 GCC Countries Non-Invasive Prenatal Testing Market, by Method, 2017-2022 (US$ Mn)
TABLE 367 GCC Countries Non-Invasive Prenatal Testing Market, by Method, 2023-2030 (US$ Mn)
TABLE 368 GCC Countries Non-Invasive Prenatal Testing Market, by Technology, 2017-2022 (US$ Mn)
TABLE 369 GCC Countries Non-Invasive Prenatal Testing Market, by Technology, 2023-2030 (US$ Mn)
TABLE 370 GCC Countries Non-Invasive Prenatal Testing Market, by Application, 2017-2022 (US$ Mn)
TABLE 371 GCC Countries Non-Invasive Prenatal Testing Market, by Application, 2023-2030 (US$ Mn)
TABLE 372 GCC Countries Non-Invasive Prenatal Testing Market, by Products, 2017-2022 (US$ Mn)
TABLE 373 GCC Countries Non-Invasive Prenatal Testing Market, by Products, 2023-2030 (US$ Mn)
TABLE 374 GCC Countries Non-Invasive Prenatal Testing Market, by End User, 2017-2022 (US$ Mn)
TABLE 375 GCC Countries Non-Invasive Prenatal Testing Market, by End User, 2023-2030 (US$ Mn)
TABLE 376 South Africa Non-Invasive Prenatal Testing Market, by Gestation Period, 2017-2022 (US$ Mn)
TABLE 377 South Africa Non-Invasive Prenatal Testing Market, by Gestation Period, 2023-2030 (US$ Mn)
TABLE 378 South Africa Non-Invasive Prenatal Testing Market, by Pregnancy Risk, 2017-2022 (US$ Mn)
TABLE 379 South Africa Non-Invasive Prenatal Testing Market, by Pregnancy Risk, 2023-2030 (US$ Mn)
TABLE 380 South Africa Non-Invasive Prenatal Testing Market, by Method, 2017-2022 (US$ Mn)
TABLE 381 South Africa Non-Invasive Prenatal Testing Market, by Method, 2023-2030 (US$ Mn)
TABLE 382 South Africa Non-Invasive Prenatal Testing Market, by Technology, 2017-2022 (US$ Mn)
TABLE 383 South Africa Non-Invasive Prenatal Testing Market, by Technology, 2023-2030 (US$ Mn)
TABLE 384 South Africa Non-Invasive Prenatal Testing Market, by Application, 2017-2022 (US$ Mn)
TABLE 385 South Africa Non-Invasive Prenatal Testing Market, by Application, 2023-2030 (US$ Mn)
TABLE 386 South Africa Non-Invasive Prenatal Testing Market, by Products, 2017-2022 (US$ Mn)
TABLE 387 South Africa Non-Invasive Prenatal Testing Market, by Products, 2023-2030 (US$ Mn)
TABLE 388 South Africa Non-Invasive Prenatal Testing Market, by End User, 2017-2022 (US$ Mn)
TABLE 389 South Africa Non-Invasive Prenatal Testing Market, by End User, 2023-2030 (US$ Mn)
TABLE 390 Rest of Middle East and Africa Non-Invasive Prenatal Testing Market, by Gestation Period, 2017-2022 (US$ Mn)
TABLE 391 Rest of Middle East and Africa Non-Invasive Prenatal Testing Market, by Gestation Period, 2023-2030 (US$ Mn)
TABLE 392 Rest of Middle East and Africa Non-Invasive Prenatal Testing Market, by Pregnancy Risk, 2017-2022 (US$ Mn)
TABLE 393 Rest of Middle East and Africa Non-Invasive Prenatal Testing Market, by Pregnancy Risk, 2023-2030 (US$ Mn)
TABLE 394 Rest of Middle East and Africa Non-Invasive Prenatal Testing Market, by Method, 2017-2022 (US$ Mn)
TABLE 395 Rest of Middle East and Africa Non-Invasive Prenatal Testing Market, by Method, 2023-2030 (US$ Mn)
TABLE 396 Rest of Middle East and Africa Non-Invasive Prenatal Testing Market, by Technology, 2017-2022 (US$ Mn)
TABLE 397 Rest of Middle East and Africa Non-Invasive Prenatal Testing Market, by Technology, 2023-2030 (US$ Mn)
TABLE 398 Rest of Middle East and Africa Non-Invasive Prenatal Testing Market, by Application, 2017-2022 (US$ Mn)
TABLE 399 Rest of Middle East and Africa Non-Invasive Prenatal Testing Market, by Application, 2023-2030 (US$ Mn)
TABLE 400 Rest of Middle East and Africa Non-Invasive Prenatal Testing Market, by Products, 2017-2022 (US$ Mn)
TABLE 401 Rest of Middle East and Africa Non-Invasive Prenatal Testing Market, by Products, 2023-2030 (US$ Mn)
TABLE 402 Rest of Middle East and Africa Non-Invasive Prenatal Testing Market, by End User, 2017-2022 (US$ Mn)
TABLE 403 Rest of Middle East and Africa Non-Invasive Prenatal Testing Market, by End User, 2023-2030 (US$ Mn)

Frequently asked questions:

How does COVID-19 Impact the global Non-Invasive Prenatal Testing market?

The COVID-19 pandemic affected the non-invasive prenatal testing (NIPT) market due to the suspension of non-invasive prenatal screening (NIPS) services to prevent the COVID-19 virus’s spread. One of the factors inhibiting hospitals and diagnostic centers from providing non-invasive prenatal screening (NIPS) services was the immense burden on hospitals to provide services to COVID-19 patients.

Which is the leading region of the market for Non-Invasive Prenatal Testing?

North America accounted for the most heightened share in the global non-invasive prenatal testing market.

What are the key drivers for the growth of the Non-Invasive Prenatal Testing market?

Prenatal testing witnesses a shift towards noninvasive tests, and the growing prevalence of chromosomal abnormalities to augment demand for NIPT industry drive the non-invasive prenatal testing market.

Which is the major segment in the Non-Invasive Prenatal Testing market by pregnancy risks?

The high and average risks segment had a major share in the global market in 2022.

Which is the major segment in the Non-Invasive Prenatal Testing market by gestation period?

The 13-24 weeks gestation period segment had a major share in the global market.

Vietnam Medical Laser Market

Published:
Report ID: 38377

Atrial Fibrillation Devices Market

Published:
Report ID: 2420

Atherectomy Devices Market

Published:
Report ID: 2391

US Pharmacy Automation Market

Published:
Report ID: 38274

Veterinary Hematology Analyzers Market

Published:
Report ID: 11808

Franz Cell and Vapometer Market

Published:
Report ID: 37491

Europe Elderly Care Services Market

Published:
Report ID: 37291

Blood and Fluid Warming Systems Market

Published:
Report ID: 2312

India Wound Care Market

Published:
Report ID: 37156

Negative Pressure Wound Therapy Market

Published:
Report ID: 14408

Smart Insulin Pens Market

Published:
Report ID: 37000

Ophthalmic Viscoelastic Devices Market

Published:
Report ID: 36996

Purchase Options

$2999
Delivery Format: Excel.
$4999
Designed for the individual purchaser.
$6999
Users located at a single corporate site or regional office.
$7999
Allowed for unlimited sharing globally within one company.
Smallform of Sample request

Have a question?

User Profile

Don’t settle for less – trust Mitul to help you find the best solution.

Report delivery within 24 to 48 hours

– Other Info –

What people say?-

User Review

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –

Phone

+91 6232 49 3207


support

24/7 Research Support


sales@credenceresearch.com

– Research Methodology –

Going beyond the basics: advanced techniques in research methodology

– Trusted By –

Pepshi, LG, Nestle
Motorola, Honeywell, Johnson and johnson
LG Chem, SIEMENS, Pfizer
Unilever, Samsonite, QIAGEN